Coarctation of the Aorta

Congenital MONDO:0007345 Pathograph 20 Show in embeddings browser

A congenital narrowing of the thoracic aorta, characteristically at the isthmus adjacent to the ductus arteriosus, accounting for roughly 5-8% of congenital heart disease. It is the most surgically satisfying of the congenital heart lesions and the most misleading. The obstruction can be excised or dilated, the gradient abolished, and the anatomy made to look normal - and yet the majority of patients are hypertensive again within a few years, and late cardiovascular mortality stays high. The reason is that the narrowing is a local expression of a diffuse arteriopathy, not the disease itself. The pre-coarctation vessels are structurally abnormal - stiffer, with impaired endothelium-dependent and endothelium-independent dilation - and remain so after the obstruction is relieved. Sympathetic outflow is elevated and the baroreflex is blunted; the renin-angiotensin system is primed before any operation, and the preoperative renin concentration predicts hypertension years later. What the surgeon removes is the segment. What persists is the vascular phenotype, which then drives accelerated atherosclerosis, coronary disease, stroke, and premature death. Coarctation is therefore best modeled as a systemic arterial disease with a focal anatomic signature, and the entry is organized so that the post-repair arm is not a complication of treatment but the natural history that treatment fails to interrupt.

Ask OpenScientist

Ask a research question about Coarctation of the Aorta. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Inheritance
12
Pathophys.
7
Phenotypes
2
Hypotheses
3
Gaps
20
Pathograph
3
Genes
4
Medical Actions
1
Models
1
Deep Research
👪

Inheritance

1
Multifactorial (polygenic) inheritance HP:0010982
Coarctation sits within the left-sided obstructive lesion spectrum, which is clearly heritable - nonsyndromic defects recur in families and carry a high sibling recurrence risk - without following a Mendelian pattern. The currently accepted genes for this spectrum explain only 10-20% of patients, and the emerging picture is combinatorial: common and rare variants acting together. That is why the three genes curated below are all typed SUSCEPTIBILITY rather than causative, despite NOTCH1 and MYH6 being well-replicated associations.
Polygenic inheritance
Show evidence (4 references)
PMID:33432820 SUPPORT Other
"nonsyndromic defects are often observed in multiple family members and associated with high sibling recurrence risk. This clear evidence for a heritable basis has driven a lengthy search for disease-causing variants"
Establishes familial recurrence and a heritable basis for the left-sided obstructive lesion spectrum that includes coarctation.
PMID:33432820 SUPPORT Other
"the currently accepted LSOL-associated genes explain only 10% to 20% of patients. Further, the combinatorial effects of common and rare variants as a cause of LSOLs are emerging."
Quantifies the unexplained majority and supports a combinatorial rather than Mendelian architecture, which is what justifies a polygenic record. Evidence source is OTHER because this is a narrative review, matching how the other review cited in this entry is classified.
PMID:33432820 SUPPORT Other
"The risk of CHD varies by the proband's defect but is higher than the general population with prevalence in first‐degree relatives of 19% for HLHS, 9% for CoA, and 1% for transposition of the great arteries."
Quantifies familial aggregation stratified by proband defect. Note what the 9% figure does and does not measure: it is the prevalence of *any* congenital heart defect among first-degree relatives of a coarctation proband, not recurrence of coarctation itself. That distinction matters here rather than being pedantic - a familial excess of heterogeneous left-sided lesions is what a shared developmental program predicts, and is weaker evidence for a coarctation-specific recurrence risk than the raw number suggests. Evidence source is OTHER because this is a narrative review.
+ 1 more reference
◈

Mechanistic Hypotheses

2
Ectopic ductal tissue constriction
ductal_tissue_migration CANONICAL
Evidence balance 2 support
Contractile tissue of ductus arteriosus type extends ectopically into the aortic isthmus; when the ductus constricts after birth, the ectopic tissue contracts with it and draws in the aortic wall. This is the traditional account and explains the juxtaductal location of the shelf and the timing of neonatal decompensation at ductal closure. It predicts that the narrowing is an active, tissue-intrinsic constriction rather than a growth failure. The PRDM6 association - a smooth-muscle-specific transcription factor causal for patent ductus arteriosus and reported in patients who also have coarctation - is the most direct contemporary support for a shared ductal/aortic smooth-muscle lesion, though it falls short of demonstrating the ectopic tissue itself.
Pathograph links
Ectopic Ductal Tissue at the Aortic Isthmus -> Fixed Aortic Obstruction and Pressure Gradient DIRECT Contraction of the ectopic ductal tissue narrows the isthmic lumen.
Left Ventricular Outflow Tract Developmental Program Disruption -> Ectopic Ductal Tissue at the Aortic Isthmus INDIRECT UNKNOWN INTERMEDIATES A smooth-muscle-identity lesion such as PRDM6 loss is a plausible route to misplaced ductal-type tissue, linking the genetic trigger to the ductal-tissue account.
Show evidence (2 references)
PMID:7057615 SUPPORT Human Clinical
"localized stenosis is related to abnormal distribution of the ductal tissue to the descending aorta and post-natal constriction of the ductus arteriosus."
States this hypothesis in the terms curated here, as the account of the localized stenosis component specifically.
PMID:38071433 SUPPORT INDIRECT Human Clinical
"Pathogenic variants in PRDM6, which encodes a smooth-muscle-cell-specific transcription factor, have now been etiologically associated with non-syndromic PDA."
Supports a shared smooth-muscle-identity lesion linking the ductus and the aortic phenotype. Graded INDIRECT because it does not demonstrate ectopic ductal tissue in the isthmus.
Reduced fetal isthmic flow
reduced_fetal_flow ALTERNATIVE
Evidence balance 3 support
Any fetal lesion diverting blood from the ascending aorta and arch reduces antegrade flow through the isthmus, which then fails to grow. This predicts exactly the clustering that is observed - coarctation with bicuspid or stenotic aortic valve, with ventricular septal defect, with arch or descending aortic hypoplasia - and predicts that isolated coarctation should be the exception rather than the rule. It is the same reasoning applied to hypoplastic left heart syndrome, and it shares that debate's central difficulty: the association is compatible with reduced flow causing the hypoplasia and with a shared developmental lesion causing both.
Pathograph links
Reduced Antegrade Flow Through the Fetal Aortic Isthmus -> Fixed Aortic Obstruction and Pressure Gradient INDIRECT KNOWN INTERMEDIATES An isthmus that did not grow adequately in fetal life presents after birth as a fixed narrowing.
Left Ventricular Outflow Tract Developmental Program Disruption -> Reduced Antegrade Flow Through the Fetal Aortic Isthmus INDIRECT UNKNOWN INTERMEDIATES Disruption of the shared outflow-tract program produces the valve and arch lesions that reduce isthmic flow.
Show evidence (3 references)
PMID:7057615 SUPPORT Human Clinical
"ischemic hypoplasia results from prenatal decrease of blood flow to the ascending aorta"
States this hypothesis in the terms curated here, as the account of the hypoplastic component specifically.
PMID:24418111 SUPPORT Human Clinical
"in approximately half of the cases, it was combined with hypoplasia of the aortic arch or descending aorta."
Documents the coexisting arch and descending aortic hypoplasia that the flow account predicts.
PMID:33432820 SUPPORT Other
"only 16.2% of patients with CoA have isolated disease, whereas the majority have concomitant cardiac defects."
The population-level prediction of this hypothesis, quantified: if coarctation arises because some other lesion diverted fetal flow, isolated coarctation should be the exception. It is - by a factor of five. Evidence source is OTHER because this is a narrative review.
?

Discussions and Knowledge Gaps

3
Does the isthmic narrowing arise from constriction of ectopic ductal tissue, from failure of an underperfused isthmus to grow, or from both in different patients?
CONTROVERSY coa_morphogenesis_ductal_vs_flow
Attached to
pathophysiology#Ectopic Ductal Tissue at the Aortic Isthmus pathophysiology#Reduced Antegrade Flow Through the Fetal Aortic Isthmus
The two accounts predict different things about what repair can achieve. If the lesion is an active constriction of misplaced ductal muscle, the aorta proximal and distal to it may be structurally normal and complete excision should be curative. If the isthmus failed to grow because it was underperfused, the whole left-heart-and-arch complex is developmentally abnormal and the narrowing is one visible part of a larger lesion. The persistence of hypertension and arteriopathy after technically perfect repair is easier to reconcile with the second, but does not settle it, because a shared genetic program could produce both the ductal-tissue anomaly and the arterial wall abnormality independently. Contemporary genetics is uncomfortable for a clean separation: PRDM6 is a smooth-muscle-identity gene implicated in the ductal lesion, while MYH6 and NOTCH1 sit in the outflow-tract program that the flow account invokes.
Proposed experiments
Prospective fetal flow measurement in isthmic narrowing
exp_coa_isthmic_flow_fetal_imaging
Serially quantify antegrade isthmic flow by fetal echocardiography in pregnancies at risk of coarctation, and relate flow trajectory to postnatal isthmic dimensions and to the presence of a discrete posterior shelf. A shelf appearing in fetuses with preserved isthmic flow would support the ductal-tissue account; progressive isthmic hypoplasia tracking with falling flow would support the growth-failure account.
Histologic and transcriptional characterization of resected coarctation segments by genotype
exp_coa_resected_segment_histology_genotype
Characterize resected coarctation segments for ductal-type smooth muscle markers and compare across genotype strata (PRDM6, MYH6, NOTCH1 variant carriers versus non-carriers). Enrichment of ductal-type tissue in PRDM6 carriers specifically would connect the genetic and morphogenetic accounts rather than leaving them as parallel narratives.
Show evidence (1 reference)
PMID:7057615 SUPPORT Human Clinical
"ischemic hypoplasia results from prenatal decrease of blood flow to the ascending aorta, and localized stenosis is related to abnormal distribution of the ductal tissue to the descending aorta and post-natal constriction of the ductus arteriosus."
The clearest statement that both accounts are needed - one for the hypoplastic component and one for the localized stenosis. Graded PARTIAL because the authors present it explicitly as a working hypothesis compatible with their angiographic findings, not as a demonstrated morphogenesis.
Is the arteriopathy of the pre-coarctation vasculature developmentally intrinsic, or acquired from years of exposure to elevated proximal pressure?
KNOWLEDGE GAP coa_arteriopathy_intrinsic_vs_acquired
Attached to
pathophysiology#Diffuse Arteriopathy of the Pre-Coarctation Vasculature
This determines whether earlier repair can prevent it or only limit it. The evidence points both ways. Abnormality of the endothelium-independent nitrate response argues for a structural, and plausibly intrinsic, wall defect rather than a purely functional consequence of hypertension. But the same abnormalities are documented in patients repaired in the first months of life and followed for decades, so exposure duration was already minimal and the abnormality persisted - which is consistent with an intrinsic defect and equally consistent with an irreversible early insult. No study has compared pre-coarctation arterial structure in fetuses or neonates before any significant pressure exposure has occurred.
Proposed experiments
Arterial wall characterization in neonates before significant pressure exposure
exp_coa_neonatal_arterial_wall_before_exposure
Measure proximal arterial stiffness and endothelium-dependent and -independent function in neonates with prenatally diagnosed coarctation before repair and before prolonged hypertensive exposure, comparing with matched controls. Abnormality already present at this point would establish the arteriopathy as intrinsic rather than acquired.
Should the accelerated-atherosclerosis node declare conformance to the `atherogenesis` module?
CURATION TODO coa_atherogenesis_module_conformance
Attached to
pathophysiology#Accelerated Atherosclerosis and Late Cardiovascular Mortality
Mechanistically it very likely should. The module's core chain is apoB lipoprotein retention at a dysfunctional endothelium, foam-cell formation, and smooth-muscle-cell fibrofatty plaque assembly, and repaired coarctation supplies exactly the endothelial dysfunction and hypertensive substrate that chain begins from. What is missing is evidence: the source cited here is a review reporting the prevalence of atherosclerotic sequelae in this population, which establishes that plaques accumulate faster, not that they are assembled by the module's mechanism in these patients specifically. Declaring conformance on that basis would assert mechanism from epidemiology. Left as an explicit curation task rather than a silent omission.
⚙

Pathophysiology

12
Ectopic Ductal Tissue at the Aortic Isthmus
On the ductal-tissue account, contractile smooth muscle of ductus arteriosus type extends ectopically into the wall of the aortic isthmus. When the ductus constricts and closes after birth, this ectopic tissue contracts with it, drawing the posterior aortic wall inward as a shelf. The account explains the characteristic juxtaductal location of the narrowing and the timing of neonatal decompensation, which follows ductal closure rather than birth.
Ectopic ductal tissue constriction
aortic smooth muscle cell CL:0000359 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves aortic smooth muscle cell, annotated with vascular associated smooth muscle cell (CL:0000359). CL:0000359 is a cell type from the Cell Ontology.
thoracic aorta UBERON:0001515 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in thoracic aorta (UBERON:0001515). UBERON:0001515 is an anatomical location from the Uberon multi-species anatomy ontology. ductus arteriosus UBERON:0005440 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in ductus arteriosus (UBERON:0005440). UBERON:0005440 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Fixed Aortic Obstruction and Pressure Gradient Contraction of the ectopic ductal tissue narrows the isthmic lumen. Ectopic ductal tissue constriction
Show evidence (3 references)
PMID:7057615 SUPPORT Human Clinical
"localized stenosis is related to abnormal distribution of the ductal tissue to the descending aorta and post-natal constriction of the ductus arteriosus."
States the ductal-tissue account as the authors' working hypothesis for the localized stenosis component, derived from angiographic morphology.
PMID:7057615 SUPPORT Human Clinical
"The anterior ostium to the descending aorta was obstructed by constricted ductus arteriosus in some infants with COA."
Direct angiographic observation of the constricted ductus obstructing the descending aortic ostium, the anatomic event this node asserts.
PMID:7057615 SUPPORT Human Clinical
"Localized stenosis at the distal end of isthmus was present in 89%, and absent in 11% (4 cases)."
Quantifies how often a discrete localized stenosis is present, and establishes that a minority of cases lack it - the subgroup in which the ductal-tissue account cannot be the whole story.
Reduced Antegrade Flow Through the Fetal Aortic Isthmus
On the flow account, any fetal lesion that diverts blood away from the ascending aorta and arch - a bicuspid or stenotic aortic valve, a ventricular septal defect shunting left to right, a small left ventricle - reduces antegrade flow through the isthmus, and the underperfused segment fails to grow. This predicts what is observed: coarctation clusters with other left-heart obstructive lesions rather than occurring in isolation, is combined with bicuspid aortic valve in more than half of cases, and coexists with arch or descending aortic hypoplasia in about half.
Reduced fetal isthmic flow
aorta development GO:0035904 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal aorta development (GO:0035904). GO:0035904 is a biological process from the Gene Ontology. ⚠ ABNORMAL
thoracic aorta UBERON:0001515 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in thoracic aorta (UBERON:0001515). UBERON:0001515 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Fixed Aortic Obstruction and Pressure Gradient An isthmus that did not grow adequately in fetal life presents after birth as a fixed narrowing. Reduced fetal isthmic flow
Show evidence (3 references)
PMID:24418111 SUPPORT Human Clinical
"In more than half of the cases, coarctation was combined with bicuspid aortic valve, and in approximately half of the cases, it was combined with hypoplasia of the aortic arch or descending aorta."
Documents the co-occurrence with bicuspid valve and arch hypoplasia that the reduced-flow account predicts, in a consecutive clinical series.
PMID:7057615 SUPPORT Human Clinical
"ischemic hypoplasia results from prenatal decrease of blood flow to the ascending aorta"
States the reduced-fetal-flow account as the authors' working hypothesis for the hypoplastic component, in the same angiographic study that proposes the ductal-tissue account for the localized stenosis.
PMID:7057615 SUPPORT Human Clinical
"In COA, the isthmus was narrower than the controls in 88% of the cases"
Quantifies isthmic hypoplasia against age-matched controls, the morphologic claim of this node.
Left Ventricular Outflow Tract Developmental Program Disruption
Coarctation is highly heritable and sits within a genetically shared spectrum of left ventricular outflow tract malformations. NOTCH1 variants recur across bicuspid aortic valve, aortic aneurysm, hypoplastic left heart, and coarctation. A rare MYH6 missense variant carried by around a fifth of Icelandic coarctation cases associates with coarctation and with bicuspid valve. PRDM6, a smooth-muscle-specific transcription factor already implicated in patent ductus arteriosus, links the ductal and aortic lesions at the level of smooth muscle identity - the same cell type the ductal-tissue hypothesis invokes. Loss of one X chromosome short arm in Turner syndrome reproduces the bicuspid-valve/coarctation pair, localizing a dosage-sensitive contribution to Xp.
Ectopic ductal tissue constriction Reduced fetal isthmic flow
NOTCH1 hgnc:7881 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves NOTCH1 (hgnc:7881). hgnc:7881 is a gene from the HUGO Gene Nomenclature Committee. MYH6 hgnc:7576 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves MYH6 (hgnc:7576). hgnc:7576 is a gene from the HUGO Gene Nomenclature Committee. PRDM6 hgnc:9350 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves PRDM6 (hgnc:9350). hgnc:9350 is a gene from the HUGO Gene Nomenclature Committee.
Downstream
Reduced Antegrade Flow Through the Fetal Aortic Isthmus Disruption of the shared outflow-tract program produces the valve and arch lesions that reduce isthmic flow. Reduced fetal isthmic flow
Ectopic Ductal Tissue at the Aortic Isthmus A smooth-muscle-identity lesion such as PRDM6 loss is a plausible route to misplaced ductal-type tissue, linking the genetic trigger to the ductal-tissue account. Ectopic ductal tissue constriction
Diffuse Arteriopathy of the Pre-Coarctation Vasculature The same developmental program builds the upstream arterial wall, which is abnormal independently of the obstruction.
Show evidence (5 references)
PMID:29590334 SUPPORT Human Clinical
"Approximately 20% of individuals with CoA in Iceland carry this mutation. We show that p.Arg721Trp also associates with other CHDs, in particular bicuspid aortic valve."
Quantifies a single MYH6 variant's contribution to coarctation in a population-based genome-wide study and links it to the bicuspid valve.
PMID:29590334 SUPPORT Human Clinical
"It is increasingly recognized as a highly heritable condition."
Supports the heritability claim underpinning a developmental-genetic trigger node.
PMID:24418111 SUPPORT Human Clinical
"We conclude that the R1279H substitution in the NOTCH1 gene is significantly overrepresented in patients with aortic coarctation"
Supports a NOTCH1 contribution, graded PARTIAL because this is a single targeted-screening study of 51 children reporting overrepresentation of one substitution, not an established causal assignment.
+ 2 more references
Fixed Aortic Obstruction and Pressure Gradient
The narrowed isthmus imposes a fixed resistance between the proximal and distal aorta, producing systolic hypertension in the arms and head with reduced pulse and perfusion pressure below the lesion. The gradient is the proximate cause of the classic examination findings and the substrate for everything downstream, but it is also the only part of the disease that surgery reliably removes.
regulation of blood pressure GO:0008217 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal regulation of blood pressure (GO:0008217). GO:0008217 is a biological process from the Gene Ontology. ⚠ ABNORMAL
thoracic aorta UBERON:0001515 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in thoracic aorta (UBERON:0001515). UBERON:0001515 is an anatomical location from the Uberon multi-species anatomy ontology.
Animal models
Rat suprarenal aortic banding model Rattus norvegicus partially recapitulates A fixed aortic obstruction with the kidneys distal to it, matching the human pressure distribution.
Downstream
Renin-Angiotensin System Activation Reduced perfusion pressure at the renal arteries, which lie distal to the coarctation, stimulates renin release.
Left Ventricular Pressure Overload and Hypertrophy The ventricle must generate supranormal systolic pressure to drive flow across the obstruction.
Ductal-Dependent Systemic Perfusion in Critical Coarctation When the narrowing is severe, systemic flow below the lesion depends on right-to-left shunting through the patent ductus arteriosus.
Collateral Arterial Development The pressure gradient across the obstruction drives flow through, and progressive enlargement of, intercostal, internal thoracic, and subscapular arteries that bypass it.
Show evidence (1 reference)
PMID:40283210 SUPPORT Human Clinical
"Coarctation of the aorta (CoA) represents 5% to 7% of all congenital heart diseases. Surgery and interventional methods offer great short-term results"
Establishes the lesion's frequency and the fact that mechanical relief of the obstruction is reliably achievable in the short term.
Renin-Angiotensin System Activation
The kidneys sit downstream of the coarctation and sense the reduced perfusion pressure as volume depletion, activating the renin-angiotensin system and raising systemic pressure further - a feedback loop that cannot correct the sensed deficit because the obstruction, not volume status, is what limits renal perfusion. Renin activation is present preoperatively and is not merely a response to the residual gradient: the preoperative renin concentration independently predicts hypertension two years after successful repair, which is why this node feeds the persistent-hypertension arm and not only the acute one.
renin-angiotensin regulation of aldosterone production GO:0002018 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased renin-angiotensin regulation of aldosterone production (GO:0002018). GO:0002018 is a biological process from the Gene Ontology. ↑ INCREASED positive regulation of vasoconstriction GO:0045907 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased positive regulation of vasoconstriction (GO:0045907). GO:0045907 is a biological process from the Gene Ontology. ↑ INCREASED
aorta UBERON:0000947 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in aorta (UBERON:0000947). UBERON:0000947 is an anatomical location from the Uberon multi-species anatomy ontology.
Animal models
Rat suprarenal aortic banding model Rattus norvegicus recapitulates Banding above the renal arteries places the kidneys in the low-pressure compartment, reproducing the renal hypoperfusion that drives renin release in human coarctation. This is the mechanism the model exists to isolate.
Downstream
Persistent Hypertension After Anatomic Repair Neurohormonal priming established before repair persists after the gradient is abolished.
Show evidence (2 references)
PMID:40283210 SUPPORT Human Clinical
"preoperative renin plasma concentration above the upper normal level (46.1 μUI/mL) was independently associated with the occurrence of hypertension (OR = 2.49, 95% CI = 2.001-5.03, p = 0.001)."
Quantifies preoperative renin as an independent predictor of postoperative hypertension, the claim that makes this node upstream of persistent rather than merely acute hypertension.
PMID:40283210 SUPPORT Human Clinical
"The renin-angiotensin system plays a significant part in the etiology of vascular dysfunction in these patients, and several studies report increased preoperative and postoperative levels"
Supports renin-angiotensin activation both before and after repair.
Collateral Arterial Development
Over months to years, flow bypasses the obstruction through enlarging intercostal, internal thoracic, and subscapular arteries. Collateralization is protective - it maintains distal perfusion and can render an anatomically severe coarctation clinically silent into adulthood - and is simultaneously the reason presentation is so often delayed until hypertension or a complication supervenes. The enlarged intercostal arteries erode the inferior rib margins, producing the classical radiographic notching.
arterial endothelial cell CL:0000115 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves arterial endothelial cell, annotated with endothelial cell (CL:0000115). CL:0000115 is a cell type from the Cell Ontology.
thoracic aorta UBERON:0001515 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in thoracic aorta (UBERON:0001515). UBERON:0001515 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Persistent Hypertension After Anatomic Repair Collateralization delays diagnosis by preserving distal perfusion, so the obstruction and its neurohormonal consequences persist untreated for longer. The intermediates between duration of untreated obstruction and post-repair hypertension are not established, hence the weak edge typing.
Show evidence (3 references)
PMID:40671984 SUPPORT Human Clinical
"CT angiography (CTA) confirmed a severe coarctation, with a minimal luminal diameter of 3 mm, located 38 mm distal to the left subclavian artery, and extensive collateral circulation via intercostal and internal mammary arteries."
Documents the intercostal and internal mammary collateral network in a severe coarctation, the vessels this node asserts enlarge.
PMID:40671984 SUPPORT Human Clinical
"Chest X-ray revealed rib notching and the classic "3-sign," raising suspicion of aortic coarctation."
Supports the radiographic rib notching produced by enlarged intercostal arteries.
PMID:40671984 SUPPORT Human Clinical
"A 42-year-old man with a 24-year history of poorly controlled hypertension was admitted following a traumatic femoral fracture."
Supports the delayed-presentation claim: a severe coarctation went anatomically undiagnosed into the fifth decade, presenting only through its hypertensive consequence and then incidentally.
Ductal-Dependent Systemic Perfusion in Critical Coarctation
In the most severe form, the neonate is well while the ductus arteriosus is open because systemic flow below the coarctation is supplied right-to-left across it. Ductal closure in the first days of life abruptly removes that supply, producing shock, acidosis, and heart failure. The presentation is therefore timed by ductal physiology rather than by the anatomy, and it is reversible in the short term by reopening the ductus pharmacologically.
ductus arteriosus UBERON:0005440 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in ductus arteriosus (UBERON:0005440). UBERON:0005440 is an anatomical location from the Uberon multi-species anatomy ontology.
Show evidence (1 reference)
PMID:10771966 SUPPORT Human Clinical
"lesions with ductus dependent systemic blood flow e.g. critical aortic stenosis, coarctation of aorta, interruption of aortic arch"
Classifies coarctation explicitly among the lesions with ductus-dependent systemic blood flow, the claim of this node.
Left Ventricular Pressure Overload and Hypertrophy
The left ventricle hypertrophies against the elevated afterload. Ventricular mass in repaired coarctation tracks ambulatory rather than clinic blood pressure, and the relationship is steeper than in healthy controls - the same daytime pressure buys more hypertrophy in a coarctation patient. Left ventricular mass is itself a predictor of late morbidity and mortality, so this node is not merely a marker of load.
cardiomyocyte CL:0000746 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves cardiomyocyte, annotated with cardiac muscle cell (CL:0000746). CL:0000746 is a cell type from the Cell Ontology.
heart left ventricle UBERON:0002084 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in heart left ventricle (UBERON:0002084). UBERON:0002084 is an anatomical location from the Uberon multi-species anatomy ontology.
Show evidence (2 references)
PMID:12821257 SUPPORT Human Clinical
"Systolic BP at 24 h was an independent predictor of LV mass, having an accentuated impact in coarctation subjects as compared with controls."
Supports both the pressure-mass relationship and its accentuation specific to coarctation.
PMID:12821257 SUPPORT Human Clinical
"Patients had higher 24-h systolic BP and LV mass than controls."
Documents hypertrophy in successfully repaired patients relative to healthy volunteers.
Diffuse Arteriopathy of the Pre-Coarctation Vasculature
The arteries proximal to the coarctation are intrinsically abnormal, not merely exposed to high pressure. In repaired patients both endothelium-dependent flow-mediated dilation and the response to the endothelium-independent smooth muscle dilator glyceryl trinitrate are reduced, and pulse wave velocity is increased - the second of those is the decisive observation, because a purely endothelial defect would spare the nitrate response. Arterial stiffness and endothelial dysfunction persist decades after early repair. This node is the reason coarctation is a systemic disease rather than a segmental one.
arterial endothelial cell CL:0000115 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves arterial endothelial cell, annotated with endothelial cell (CL:0000115). CL:0000115 is a cell type from the Cell Ontology. arterial smooth muscle cell CL:0000359 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves arterial smooth muscle cell, annotated with vascular associated smooth muscle cell (CL:0000359). CL:0000359 is a cell type from the Cell Ontology.
aorta UBERON:0000947 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in aorta (UBERON:0000947). UBERON:0000947 is an anatomical location from the Uberon multi-species anatomy ontology.
Animal models
Rat suprarenal aortic banding model Rattus norvegicus fails to recapitulate Recorded as a negative link so the model is not read as validating the systemic-arteriopathy arm of this entry.
Downstream
Persistent Hypertension After Anatomic Repair Stiff, poorly dilating conduit arteries raise systolic pressure independently of any residual obstruction.
Accelerated Atherosclerosis and Late Cardiovascular Mortality Endothelial dysfunction and vascular wall abnormality are the substrate on which atherosclerotic disease accumulates prematurely.
Show evidence (2 references)
PMID:12821257 SUPPORT Human Clinical
"Both endothelium-dependent FMD and the response to the smooth muscle dilator GTN were reduced, and PWV was increased."
The core evidence that the abnormality is not confined to the endothelium: the endothelium-independent nitrate response is impaired too.
PMID:28545853 SUPPORT Human Clinical
"After coarctation repair patients have increased muscle sympathetic nerve activity, dampened sympathetic baroreflex response, endothelial dysfunction, and increased ambulatory arterial stiffness index"
Documents persistent endothelial dysfunction and arterial stiffening a median 26 years after repair, alongside autonomic abnormalities.
Elevated Sympathetic Outflow and Baroreflex Impairment
Directly measured muscle sympathetic nerve activity is elevated in repaired coarctation patients and the sympathetic baroreflex is dampened, while the cardiac baroreflex is preserved - a dissociation suggesting the abnormality lies in the arterial baroreceptor limb rather than in central autonomic control generally. Because the carotid and aortic baroreceptors sit in the abnormal proximal vasculature, this is plausibly the arteriopathy expressing itself through the autonomic nervous system rather than a separate lesion.
Downstream
Persistent Hypertension After Anatomic Repair Elevated sympathetic tone with a blunted buffering reflex sustains hypertension after the gradient is removed.
Show evidence (2 references)
PMID:28545853 SUPPORT Human Clinical
"Coarctation patients had elevated muscle sympathetic nerve activity compared with controls"
Direct measurement of elevated sympathetic outflow rather than an inference from blood pressure.
PMID:28545853 SUPPORT Human Clinical
"dampened sympathetic baroreflex function (-2.2±2.1 vs. -7.0±5.6 bursts/100heartbeats·mm·Hg-1, p=0.007), normal cardiac baroreflex function"
Supports selective impairment of the sympathetic baroreflex limb, quoting it alongside the preserved cardiac baroreflex measured in the same patients. The dissociation is the point: a global autonomic lesion would have impaired both.
Persistent Hypertension After Anatomic Repair
Hypertension recurs or persists in a large fraction of patients despite a technically successful repair and no residual gradient - 58.5% at two years in a series repaired predominantly under one month of age. It is the convergence point of three upstream processes that repair does not touch: neurohormonal priming, the diffuse arteriopathy, and autonomic dysregulation. Patients with normal clinic pressures may still be hypertensive on ambulatory monitoring, so the phenotype is systematically under-detected by the measurement most clinics use.
regulation of blood pressure GO:0008217 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves abnormal regulation of blood pressure (GO:0008217). GO:0008217 is a biological process from the Gene Ontology. ⚠ ABNORMAL
Downstream
Left Ventricular Pressure Overload and Hypertrophy Sustained systemic hypertension continues to load the ventricle after the obstruction is gone.
Accelerated Atherosclerosis and Late Cardiovascular Mortality Chronic hypertension is a principal driver of the premature atherosclerotic burden in this population.
Show evidence (3 references)
PMID:40283210 SUPPORT Human Clinical
"A follow-up at two years revealed an incidence of 58.5% of hypertension."
Quantifies persistent hypertension after early repair, the central claim of this node.
PMID:12821257 SUPPORT Human Clinical
"patients with normal resting blood pressure (BP) may have hypertension during daily life and LV hypertrophy."
Supports systematic under-detection of the hypertensive phenotype by clinic measurement.
PMID:39926128 SUPPORT Other
"there is a high prevalence of hypertension and late cardiovascular mortality in patients with CoA despite successful repair."
States the persistence of hypertension despite successful repair. Evidence source is OTHER because this is a review.
Accelerated Atherosclerosis and Late Cardiovascular Mortality
Repaired coarctation patients accumulate coronary artery disease, coronary and aortic calcium, stroke, and peripheral arterial disease earlier than expected, and late cardiovascular mortality remains high. This is the endpoint that makes the entry's framing necessary: it is not a complication of the operation, it is what the arteriopathy does over decades while the repaired anatomy looks normal. The burden is growing in absolute terms as the adult congenital heart disease population expands and ages.
Show evidence (3 references)
PMID:39926128 SUPPORT Other
"the prevalence of atherosclerosis and associated sequelae in repaired CoA including coronary artery disease, coronary artery calcium, aortic calcium, stroke, and peripheral artery disease"
Enumerates the atherosclerotic sequelae asserted by this node. Evidence source is OTHER because this is a contemporary review.
PMID:39926128 SUPPORT Other
"The growing impact of acquired cardiovascular disease remains a significant concern as the adult congenital heart disease population continues to rapidly expand and age."
Supports the growing absolute burden claim.
PMID:40283210 SUPPORT Human Clinical
"the occurrence of postoperative hypertension associated with cardiovascular and cerebral vascular disease increases mortality and morbidity in the long term."
Links postoperative hypertension to long-term cardiovascular and cerebrovascular mortality.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Coarctation of the Aorta Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

7
Cardiovascular 6
Coarctation of Aorta HP:0001680 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Coarctation of aorta (HP:0001680). HP:0001680 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:29590334 SUPPORT Human Clinical
"Coarctation of the aorta (CoA) accounts for 4-8% of congenital heart defects (CHDs) and confers substantial morbidity despite treatment."
Establishes the lesion and its share of congenital heart disease.
Hypertension FREQUENT HP:0000822 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hypertension (HP:0000822). HP:0000822 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:40283210 SUPPORT Human Clinical
"A follow-up at two years revealed an incidence of 58.5% of hypertension."
Quantifies hypertension frequency after early repair, supporting the FREQUENT band.
Bicuspid Aortic Valve FREQUENT HP:0001647 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Bicuspid aortic valve (HP:0001647). HP:0001647 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:24418111 SUPPORT Human Clinical
"In more than half of the cases, coarctation was combined with bicuspid aortic valve"
Directly quantifies the association in a consecutive coarctation series, supporting the FREQUENT band.
Left Ventricular Hypertrophy HP:0001712 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Left ventricular hypertrophy (HP:0001712). HP:0001712 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:12821257 SUPPORT Human Clinical
"Patients had higher 24-h systolic BP and LV mass than controls."
Documents increased ventricular mass in repaired coarctation versus healthy controls.
Ventricular Septal Defect HP:0001629 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Ventricular septal defect (HP:0001629). HP:0001629 is a phenotype from the Human Phenotype Ontology.
Cerebral Berry Aneurysm HP:0007029 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cerebral berry aneurysm (HP:0007029). HP:0007029 is a phenotype from the Human Phenotype Ontology.
No `frequency` band is asserted. The association is well described clinically, but no source cited in this entry quantifies it, and a frequency band is a separate quantitative claim from the association itself. Per the project's frequency-evidence guidance, the band is omitted rather than guessed.
Other 1
Cardiogenic Shock HP:0030149 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cardiogenic shock (HP:0030149), qualified as temporality acute. HP:0030149 is a phenotype from the Human Phenotype Ontology.
Temporal: ACUTE
Show evidence (1 reference)
PMID:10771966 SUPPORT Human Clinical
"lesions with ductus dependent systemic blood flow e.g. critical aortic stenosis, coarctation of aorta, interruption of aortic arch"
Supports coarctation as a ductus-dependent systemic-flow lesion, the physiology whose interruption produces neonatal shock.
🧬

Genetic Associations

3
MYH6
Gene: MYH6 hgnc:7576 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is MYH6 (hgnc:7576). hgnc:7576 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: SUSCEPTIBILITY
Show evidence (1 reference)
PMID:29590334 SUPPORT Human Clinical
"Approximately 20% of individuals with CoA in Iceland carry this mutation."
Quantifies the variant's carrier frequency among coarctation cases in the studied population.
NOTCH1
Gene: NOTCH1 hgnc:7881 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is NOTCH1 (hgnc:7881). hgnc:7881 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: SUSCEPTIBILITY
Show evidence (1 reference)
PMID:24418111 SUPPORT Human Clinical
"This variant was significantly overrepresented in the patients with aortic coarctation compared with those in the control group"
Supports an association from a single targeted screen; graded PARTIAL because the variant was also present in controls and the study was small.
PRDM6
Gene: PRDM6 hgnc:9350 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is PRDM6 (hgnc:9350). hgnc:9350 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: SUSCEPTIBILITY
Show evidence (1 reference)
PMID:38071433 SUPPORT Human Clinical
"We present three patients with PDA and CoA"
Supports co-occurrence of both lesions in PRDM6 variant carriers; graded PARTIAL because three patients do not establish PRDM6 as a coarctation gene.
💊

Medical Actions

4
Surgical Coarctation Repair
Action: surgical procedureNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is surgical procedure (NCIT:C15329). NCIT:C15329 is a clinical intervention from the NCI Thesaurus. Ontology label: Surgical Procedure NCIT:C15329
Resection of the coarctation segment with extended end-to-end anastomosis, or equivalent surgical reconstruction. Reliably abolishes the gradient. Earlier repair reduces but does not eliminate the risk of late hypertension.
Mechanism Target:
INHIBITS Fixed Aortic Obstruction and Pressure Gradient — Excising the narrowed segment removes the fixed resistance and the proximal-to-distal pressure gradient.
Show evidence (2 references)
PMID:40283210 SUPPORT Human Clinical
"In all except two patients, end-to-end anastomosis was used."
Documents end-to-end anastomosis as the operative technique in the cited early-repair cohort.
PMID:40283210 SUPPORT Human Clinical
"Early repair of CoA, especially under one year of life, and extended end-to-end anastomosis are reported to reduce the risk of development of HT later in life"
Supports a benefit of early repair on late hypertension. Graded PARTIAL because the same cohort still had 58.5% hypertension at two years despite repair under one month in most patients - the reduction is real and clearly incomplete.
Balloon Angioplasty and Endovascular Stenting
Action: balloon angioplastyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is balloon angioplasty (NCIT:C93007). NCIT:C93007 is a clinical intervention from the NCI Thesaurus. Ontology label: Balloon Angioplasty NCIT:C93007
Catheter-based dilation of the coarctation segment, with or without stent implantation. Avoids thoracotomy and is the usual approach to recoarctation and to older patients.
Mechanism Target:
INHIBITS Fixed Aortic Obstruction and Pressure Gradient — Mechanical dilation enlarges the stenotic lumen and relieves the gradient.
Show evidence (1 reference)
PMID:40283210 SUPPORT Human Clinical
"Surgery and interventional methods offer great short-term results"
Groups interventional (catheter-based) with surgical relief as effective in the short term.
Prostaglandin E1 Infusion
Action: PharmacotherapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Pharmacotherapy (NCIT:C15986). NCIT:C15986 is a clinical intervention from the NCI Thesaurus. NCIT:C15986
Agent: prostaglandin E1 CHEBI:15544 Chemical Entities of Biological Interest (CHEBI) Relation: this treatment uses this therapeutic agent This treatment uses prostaglandin E1 (CHEBI:15544). CHEBI:15544 is a therapeutic agent from Chemical Entities of Biological Interest.
Continuous intravenous alprostadil to maintain or reopen ductal patency in the neonate with critical coarctation, restoring ductal-dependent systemic perfusion as a bridge to definitive repair. It does not treat the coarctation; it buys time by preventing the physiologic event that unmasks it.
Mechanism Target:
ACTIVATES Ductal-Dependent Systemic Perfusion in Critical Coarctation — Maintaining ductal patency preserves right-to-left flow supplying the body below the coarctation.
Show evidence (2 references)
PMID:10771966 SUPPORT Human Clinical
"E-type prostaglandins (PGE1) can effectively maintain the patency of the ductus arteriosus in neonates."
Establishes the pharmacologic mechanism this treatment relies on.
PMID:10771966 SUPPORT Human Clinical
"It helps in stabilizing these patients prior to further surgical palliation or correction."
Supports the bridging role rather than a definitive one.
Antihypertensive Therapy
Action: antihypertensive therapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is antihypertensive therapy (NCIT:C172184). NCIT:C172184 is a clinical intervention from the NCI Thesaurus. Ontology label: Antihypertensive Therapy NCIT:C172184
Long-term blood pressure control after repair. Because a majority of patients become hypertensive again and the hypertension drives the late atherosclerotic burden, this is arguably the definitive treatment of the systemic disease - the operation treats the segment.
Mechanism Target:
INHIBITS Persistent Hypertension After Anatomic Repair — Pharmacologic pressure reduction addresses the residual hypertensive phenotype that repair leaves behind.
Show evidence (1 reference)
PMID:39926128 SUPPORT Other
"This review aims to guide optimization of long-term cardiovascular health to ultimately reduce mortality and morbidity in this young high-risk population."
Supports long-term cardiovascular risk management as the therapeutic aim after repair. Evidence source is OTHER because this is a review.
🔬

Diagnosis

3
Four-Limb Blood Pressure Gradient
The bedside finding that makes the diagnosis: a systolic pressure difference between upper and lower limbs, with diminished or delayed femoral pulses. It is also the finding most often not looked for - a severe coarctation can sit behind two decades of "poorly controlled hypertension" until someone compares an arm with a leg.
blood pressure measurement NCIT:C167233 NCI Thesaurus (NCIT)
Show evidence (1 reference)
PMID:40671984 SUPPORT Human Clinical
"Cardiovascular evaluation was prompted by a 25 mmHg systolic blood pressure difference between the left upper limb (165/90 mmHg) and the left lower limb (140/85 mmHg), along with an interscapular systolic murmur, during trauma admission, suggesting coarctation."
Documents the upper-to-lower limb gradient and interscapular murmur prompting the diagnosis, in a patient hypertensive for 24 years beforehand.
Transthoracic Echocardiography
First-line imaging, which localizes the obstruction and quantifies its severity by the transisthmic gradient, while also assessing the associated intracardiac lesions - above all the bicuspid aortic valve present in more than half of cases.
echocardiography NCIT:C16525 NCI Thesaurus (NCIT)
Show evidence (1 reference)
PMID:40671984 SUPPORT Human Clinical
"Transthoracic echocardiography (TTE) showed no intracardiac deformity and demonstrated a peak-to-peak gradient of 60 mmHg across the aortic isthmus."
Documents echocardiographic quantification of the isthmic gradient and exclusion of associated intracardiac lesions.
CT Angiography
Cross-sectional angiography defines the anatomy that determines the repair strategy - the length and minimal diameter of the narrowed segment, its distance from the left subclavian artery, and the extent of the collateral network.
computed tomography angiography NCIT:C202408 NCI Thesaurus (NCIT)
Show evidence (1 reference)
PMID:40671984 SUPPORT Human Clinical
"CT angiography (CTA) confirmed a severe coarctation, with a minimal luminal diameter of 3 mm, located 38 mm distal to the left subclavian artery, and extensive collateral circulation via intercostal and internal mammary arteries."
Documents the anatomic detail CT angiography supplies and that it drove a staged endovascular approach in this case.
📊

Prevalence

1
Metropolitan Atlanta live births, 1970-1983
Birth Prevalence 36.2 per 100,000 1–9 per 10,000
3.62 per 10,000 live births in a population-based birth defects registry (131 coarctation cases). Reported alongside aortic arch interruption (0.50) and aortic hypoplasia (0.58) per 10,000.
Show evidence (1 reference)
PMID:2274893 SUPPORT Human Clinical
"The prevalence per 10,000 live births was as follows: interruption of the aortic arch, 0.50; coarctation, 3.62; and hypoplasia of the aorta, 0.58."
Population-based birth prevalence for coarctation specifically, distinguished from the neighbouring obstructive arch malformations.
🌍

Epidemiology

2
Share of congenital heart disease
Coarctation accounts for roughly 4-8% of congenital heart defects.
Show evidence (1 reference)
PMID:29590334 SUPPORT Human Clinical
"Coarctation of the aorta (CoA) accounts for 4-8% of congenital heart defects (CHDs)"
Direct statement of the lesion's share of congenital heart disease.
Coarctation and bicuspid aortic valve in Turner syndrome
In non-mosaic 45,X Turner syndrome assessed by cardiac MRI, aortic coarctation was present in 12.5% and bicuspid aortic valve in 34%.
Show evidence (1 reference)
PMID:23825392 SUPPORT Human Clinical
"Bicuspid aortic valves (BAV) were found in 52/152 (34%) 45,X study subjects and aortic coarctation (COA) in 19/152 (12.5%)."
Quantifies both lesions in a large karyotyped Turner syndrome cohort.
🐁

Animal Models

1
Rat suprarenal aortic banding model Induced (surgical) coarctation model
Surgical banding of the abdominal aorta above the renal arteries reproduces the defining haemodynamic geometry of human coarctation: severe hypertension proximal to the obstruction, with the kidneys sitting distal to it. That is precisely the arrangement that drives renin-angiotensin activation in patients, and it is why this model bears on the renin node of this entry. Its limit is equally clear and worth stating: the band is surgical, so the model recapitulates the consequence of the obstruction and says nothing about either competing account of how the isthmus narrows. It is not a model of coarctation morphogenesis and should not be cited as one.
Species
Rattus norvegicus
Genotype
Wild-type Sprague-Dawley rat with surgical abdominal aortic banding above the renal arteries
Publication
PMID:16280280
Pathograph links
Renin-Angiotensin System Activation recapitulates fidelity: high Banding above the renal arteries places the kidneys in the low-pressure compartment, reproducing the renal hypoperfusion that drives renin release in human coarctation. This is the mechanism the model exists to isolate.
Show evidence (1 reference)
PMID:16280280 SUPPORT Model Organism
"renal hypoperfusion and the consequent activation of renin-angiotensin system may mediate this process by promoting local induction of chemoattractant and inflammatory cytokines."
States the renal-hypoperfusion to renin-angiotensin sequence directly, which is the node this link claims the model recapitulates. Evidence source is MODEL_ORGANISM because this is a rat surgical model.
Fixed Aortic Obstruction and Pressure Gradient partially recapitulates fidelity: moderate A fixed aortic obstruction with the kidneys distal to it, matching the human pressure distribution.
Limitations: The obstruction is surgical and abdominal, not a juxtaductal isthmic lesion. It reproduces the haemodynamic geometry - severe hypertension proximal, normotension distal - while saying nothing about how the human narrowing forms. Neither curated morphogenetic hypothesis is testable in this model.
Show evidence (1 reference)
PMID:16280280 SUPPORT Model Organism
"abdominal aorta coarctation (banding) above renal arteries, which causes severe HTN proximal but not distal to coarctation."
Confirms the haemodynamic geometry is reproduced - severe hypertension proximal, normotension distal. Graded PARTIAL because the obstruction is surgical and abdominal rather than a juxtaductal isthmic lesion, so the pressure distribution matches while the lesion does not. Evidence source is MODEL_ORGANISM because this is a rat surgical model.
Diffuse Arteriopathy of the Pre-Coarctation Vasculature fails to recapitulate fidelity: low Recorded as a negative link so the model is not read as validating the systemic-arteriopathy arm of this entry.
Limitations: An acutely banded normal aorta has no developmental arteriopathy. Since the persistence of hypertension after repair in patients is attributed largely to that intrinsic vascular abnormality, this model cannot address the entry's central claim - and recording that explicitly is the point of including the link.
Show evidence (1 reference)
PMID:16280280 NO_EVIDENCE Model Organism
"Sprague-Dawley rats with abdominal aorta coarctation (banding) above renal arteries, which causes severe HTN proximal but not distal to coarctation."
Substantiates the negative claim by establishing what the model actually is: an acute surgical band applied to a wild-type vessel. There is no developmental arteriopathy to recapitulate and none is reported anywhere in the paper, which is why the grading is NO_EVIDENCE rather than REFUTE - the study does not test the question, and absence of a finding in a study that never looked is not a refutation. Evidence source is MODEL_ORGANISM because this is a rat surgical model.
Show evidence (1 reference)
PMID:16280280 SUPPORT Model Organism
"We studied activation of peripheral blood leukocytes and cellular infiltration in the kidneys of Sprague-Dawley rats with abdominal aorta coarctation (banding) above renal arteries, which causes severe HTN proximal but not distal to coarctation."
Establishes the model and confirms it reproduces the proximal-hypertension, distal-normotension geometry of human coarctation. Evidence source is MODEL_ORGANISM because this is a rat surgical model.
{ }

Source YAML

click to show 
name: Coarctation of the Aorta
creation_date: "2026-08-10T13:40:00Z"
category: Congenital
disease_term:
  preferred_term: aorta coarctation
  term:
    id: MONDO:0007345
    label: aorta coarctation
description: >
  A congenital narrowing of the thoracic aorta, characteristically at the isthmus
  adjacent to the ductus arteriosus, accounting for roughly 5-8% of congenital
  heart disease. It is the most surgically satisfying of the congenital heart
  lesions and the most misleading. The obstruction can be excised or dilated, the
  gradient abolished, and the anatomy made to look normal - and yet the majority
  of patients are hypertensive again within a few years, and late cardiovascular
  mortality stays high.
  The reason is that the narrowing is a local expression of a diffuse
  arteriopathy, not the disease itself. The pre-coarctation vessels are
  structurally abnormal - stiffer, with impaired endothelium-dependent and
  endothelium-independent dilation - and remain so after the obstruction is
  relieved. Sympathetic outflow is elevated and the baroreflex is blunted; the
  renin-angiotensin system is primed before any operation, and the preoperative
  renin concentration predicts hypertension years later. What the surgeon removes
  is the segment. What persists is the vascular phenotype, which then drives
  accelerated atherosclerosis, coronary disease, stroke, and premature death.
  Coarctation is therefore best modeled as a systemic arterial disease with a
  focal anatomic signature, and the entry is organized so that the post-repair
  arm is not a complication of treatment but the natural history that treatment
  fails to interrupt.
synonyms:
- aortic coarctation
- CoA
- coarctation of aorta
notes: >
  Two competing accounts of how the isthmus narrows are curated as explicit
  `mechanistic_hypotheses` rather than blended into one causal chain, because the
  literature has not settled between them and the difference has consequences for
  what a "successful" repair should be expected to achieve. The ductal-tissue
  hypothesis holds that ectopic contractile ductal tissue encircling the isthmus
  constricts as the ductus closes; the reduced-fetal-flow hypothesis holds that
  diminished antegrade flow through the isthmus in fetal life leaves it
  hypoplastic. They are not mutually exclusive: the 1982 angiographic study that
  anchors both trigger nodes proposes them together as a two-component account -
  ischemic hypoplasia of the isthmus from reduced prenatal flow, plus a localized
  stenosis from misplaced ductal tissue. They are nonetheless kept as separate
  hypothesis groups rather than merged, because a given patient may have one
  component without the other: in that series 88% had an isthmus narrower than
  age-matched controls, but 11% had no localized stenosis at all.

  No module conformance is declared. Accelerated atherosclerosis after repair
  looks like a candidate for `atherogenesis`, and mechanistically it probably is
  - but the cited source is a review that surveys prevalence of atherosclerotic
  sequelae in repaired coarctation, not a study demonstrating the module's
  required apoB-retention -> foam cell -> smooth-muscle-cell fibrofatty-plaque
  chain in this population. Declaring conformance would assert the mechanism on
  the strength of an epidemiological association. Recorded here so a future
  curator with primary evidence can add it deliberately rather than discovering
  the omission looked accidental.

  The 1976 family study (PMID:1018301) surfaced in deep research is not cited:
  its abstract could not be verified to support a specific curated claim, and the
  heritability point is carried instead by the Icelandic genome-wide association
  study, which quantifies it.
pathophysiology:
- name: Ectopic Ductal Tissue at the Aortic Isthmus
  biological_scale: TISSUE
  role: trigger
  description: >
    On the ductal-tissue account, contractile smooth muscle of ductus arteriosus
    type extends ectopically into the wall of the aortic isthmus. When the ductus
    constricts and closes after birth, this ectopic tissue contracts with it,
    drawing the posterior aortic wall inward as a shelf. The account explains the
    characteristic juxtaductal location of the narrowing and the timing of
    neonatal decompensation, which follows ductal closure rather than birth.
  locations:
  - preferred_term: thoracic aorta
    term:
      id: UBERON:0001515
      label: thoracic aorta
  - preferred_term: ductus arteriosus
    term:
      id: UBERON:0005440
      label: ductus arteriosus
  cell_types:
  - preferred_term: aortic smooth muscle cell
    term:
      id: CL:0000359
      label: vascular associated smooth muscle cell
  evidence:
  - reference: PMID:7057615
    reference_title: "Angiocardiographic study of coarctation of the aorta--morphology and morphogenesis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      localized stenosis is related to abnormal distribution of the ductal tissue
      to the descending aorta and post-natal constriction of the ductus
      arteriosus.
    explanation: >-
      States the ductal-tissue account as the authors' working hypothesis for the
      localized stenosis component, derived from angiographic morphology.
  - reference: PMID:7057615
    reference_title: "Angiocardiographic study of coarctation of the aorta--morphology and morphogenesis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The anterior ostium to the descending aorta was obstructed by constricted
      ductus arteriosus in some infants with COA.
    explanation: >-
      Direct angiographic observation of the constricted ductus obstructing the
      descending aortic ostium, the anatomic event this node asserts.
  - reference: PMID:7057615
    reference_title: "Angiocardiographic study of coarctation of the aorta--morphology and morphogenesis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Localized stenosis at the distal end of isthmus was present in 89%, and
      absent in 11% (4 cases).
    explanation: >-
      Quantifies how often a discrete localized stenosis is present, and
      establishes that a minority of cases lack it - the subgroup in which the
      ductal-tissue account cannot be the whole story.
  downstream:
  - target: Fixed Aortic Obstruction and Pressure Gradient
    causal_link_type: DIRECT
    description: >-
      Contraction of the ectopic ductal tissue narrows the isthmic lumen.
    hypothesis_groups:
    - ductal_tissue_migration
- name: Reduced Antegrade Flow Through the Fetal Aortic Isthmus
  biological_scale: TISSUE
  role: trigger
  description: >
    On the flow account, any fetal lesion that diverts blood away from the
    ascending aorta and arch - a bicuspid or stenotic aortic valve, a ventricular
    septal defect shunting left to right, a small left ventricle - reduces
    antegrade flow through the isthmus, and the underperfused segment fails to
    grow. This predicts what is observed: coarctation clusters with other
    left-heart obstructive lesions rather than occurring in isolation, is
    combined with bicuspid aortic valve in more than half of cases, and coexists
    with arch or descending aortic hypoplasia in about half.
  locations:
  - preferred_term: thoracic aorta
    term:
      id: UBERON:0001515
      label: thoracic aorta
  biological_processes:
  - preferred_term: aorta development
    term:
      id: GO:0035904
      label: aorta development
    modifier: ABNORMAL
  evidence:
  - reference: PMID:24418111
    reference_title: "Variants in the NOTCH1 gene in patients with aortic coarctation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In more than half of the cases, coarctation was combined with bicuspid
      aortic valve, and in approximately half of the cases, it was combined with
      hypoplasia of the aortic arch or descending aorta.
    explanation: >-
      Documents the co-occurrence with bicuspid valve and arch hypoplasia that
      the reduced-flow account predicts, in a consecutive clinical series.
  - reference: PMID:7057615
    reference_title: "Angiocardiographic study of coarctation of the aorta--morphology and morphogenesis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      ischemic hypoplasia results from prenatal decrease of blood flow to the
      ascending aorta
    explanation: >-
      States the reduced-fetal-flow account as the authors' working hypothesis
      for the hypoplastic component, in the same angiographic study that proposes
      the ductal-tissue account for the localized stenosis.
  - reference: PMID:7057615
    reference_title: "Angiocardiographic study of coarctation of the aorta--morphology and morphogenesis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In COA, the isthmus was narrower than the controls in 88% of the cases
    explanation: >-
      Quantifies isthmic hypoplasia against age-matched controls, the
      morphologic claim of this node.
  downstream:
  - target: Fixed Aortic Obstruction and Pressure Gradient
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      An isthmus that did not grow adequately in fetal life presents after birth
      as a fixed narrowing.
    hypothesis_groups:
    - reduced_fetal_flow
- name: Left Ventricular Outflow Tract Developmental Program Disruption
  biological_scale: MOLECULAR
  role: trigger
  description: >
    Coarctation is highly heritable and sits within a genetically shared spectrum
    of left ventricular outflow tract malformations. NOTCH1 variants recur across
    bicuspid aortic valve, aortic aneurysm, hypoplastic left heart, and
    coarctation. A rare MYH6 missense variant carried by around a fifth of
    Icelandic coarctation cases associates with coarctation and with bicuspid
    valve. PRDM6, a smooth-muscle-specific transcription factor already
    implicated in patent ductus arteriosus, links the ductal and aortic lesions
    at the level of smooth muscle identity - the same cell type the ductal-tissue
    hypothesis invokes. Loss of one X chromosome short arm in Turner syndrome
    reproduces the bicuspid-valve/coarctation pair, localizing a dosage-sensitive
    contribution to Xp.
  genes:
  - preferred_term: NOTCH1
    term:
      id: hgnc:7881
      label: NOTCH1
  - preferred_term: MYH6
    term:
      id: hgnc:7576
      label: MYH6
  - preferred_term: PRDM6
    term:
      id: hgnc:9350
      label: PRDM6
  evidence:
  - reference: PMID:29590334
    reference_title: "A rare missense mutation in MYH6 associates with non-syndromic coarctation of the aorta."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Approximately 20% of individuals with CoA in Iceland carry this mutation.
      We show that p.Arg721Trp also associates with other CHDs, in particular
      bicuspid aortic valve.
    explanation: >-
      Quantifies a single MYH6 variant's contribution to coarctation in a
      population-based genome-wide study and links it to the bicuspid valve.
  - reference: PMID:29590334
    reference_title: "A rare missense mutation in MYH6 associates with non-syndromic coarctation of the aorta."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      It is increasingly recognized as a highly heritable condition.
    explanation: >-
      Supports the heritability claim underpinning a developmental-genetic
      trigger node.
  - reference: PMID:24418111
    reference_title: "Variants in the NOTCH1 gene in patients with aortic coarctation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We conclude that the R1279H substitution in the NOTCH1 gene is
      significantly overrepresented in patients with aortic coarctation
    explanation: >-
      Supports a NOTCH1 contribution, graded PARTIAL because this is a single
      targeted-screening study of 51 children reporting overrepresentation of one
      substitution, not an established causal assignment.
  - reference: PMID:38071433
    reference_title: "Patent ductus arteriosus and coarctation of the aorta in association with PRDM6 variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Pathogenic variants in PRDM6, which encodes a smooth-muscle-cell-specific
      transcription factor, have now been etiologically associated with
      non-syndromic PDA.
    explanation: >-
      Establishes PRDM6 as a smooth-muscle transcription factor causal for patent
      ductus arteriosus. Graded PARTIAL for coarctation specifically, since the
      report describes three patients with both lesions rather than an
      established coarctation gene.
  - reference: PMID:23825392
    reference_title: "Bicuspid aortic valve and aortic coarctation are linked to deletion of the X chromosome short arm in Turner syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Bicuspid aortic valves (BAV) were found in 52/152 (34%) 45,X study subjects
      and aortic coarctation (COA) in 19/152 (12.5%).
    explanation: >-
      Quantifies the coarctation and bicuspid-valve burden in Turner syndrome by
      cardiac MRI, supporting an Xp dosage contribution.
  downstream:
  - target: Reduced Antegrade Flow Through the Fetal Aortic Isthmus
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Disruption of the shared outflow-tract program produces the valve and arch
      lesions that reduce isthmic flow.
    hypothesis_groups:
    - reduced_fetal_flow
  - target: Ectopic Ductal Tissue at the Aortic Isthmus
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      A smooth-muscle-identity lesion such as PRDM6 loss is a plausible route to
      misplaced ductal-type tissue, linking the genetic trigger to the
      ductal-tissue account.
    hypothesis_groups:
    - ductal_tissue_migration
  - target: Diffuse Arteriopathy of the Pre-Coarctation Vasculature
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      The same developmental program builds the upstream arterial wall, which is
      abnormal independently of the obstruction.
- name: Fixed Aortic Obstruction and Pressure Gradient
  biological_scale: ORGANISM
  description: >
    The narrowed isthmus imposes a fixed resistance between the proximal and
    distal aorta, producing systolic hypertension in the arms and head with
    reduced pulse and perfusion pressure below the lesion. The gradient is the
    proximate cause of the classic examination findings and the substrate for
    everything downstream, but it is also the only part of the disease that
    surgery reliably removes.
  locations:
  - preferred_term: thoracic aorta
    term:
      id: UBERON:0001515
      label: thoracic aorta
  biological_processes:
  - preferred_term: regulation of blood pressure
    term:
      id: GO:0008217
      label: regulation of blood pressure
    modifier: ABNORMAL
  evidence:
  - reference: PMID:40283210
    reference_title: "Association of Plasma Renin Activity with Risk of Late Hypertension in Pediatric Patients with Early Aortic Coarctation Repair: A Retrospective Study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Coarctation of the aorta (CoA) represents 5% to 7% of all congenital heart
      diseases. Surgery and interventional methods offer great short-term
      results
    explanation: >-
      Establishes the lesion's frequency and the fact that mechanical relief of
      the obstruction is reliably achievable in the short term.
  downstream:
  - target: Renin-Angiotensin System Activation
    causal_link_type: DIRECT
    description: >-
      Reduced perfusion pressure at the renal arteries, which lie distal to the
      coarctation, stimulates renin release.
  - target: Left Ventricular Pressure Overload and Hypertrophy
    causal_link_type: DIRECT
    description: >-
      The ventricle must generate supranormal systolic pressure to drive flow
      across the obstruction.
  - target: Ductal-Dependent Systemic Perfusion in Critical Coarctation
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      When the narrowing is severe, systemic flow below the lesion depends on
      right-to-left shunting through the patent ductus arteriosus.
  - target: Collateral Arterial Development
    causal_link_type: DIRECT
    description: >-
      The pressure gradient across the obstruction drives flow through, and
      progressive enlargement of, intercostal, internal thoracic, and
      subscapular arteries that bypass it.
- name: Renin-Angiotensin System Activation
  biological_scale: ORGANISM
  description: >
    The kidneys sit downstream of the coarctation and sense the reduced
    perfusion pressure as volume depletion, activating the renin-angiotensin
    system and raising systemic pressure further - a feedback loop that cannot
    correct the sensed deficit because the obstruction, not volume status, is
    what limits renal perfusion. Renin activation is present preoperatively and
    is not merely a response to the residual gradient: the preoperative renin
    concentration independently predicts hypertension two years after successful
    repair, which is why this node feeds the persistent-hypertension arm and not
    only the acute one.
  locations:
  - preferred_term: aorta
    term:
      id: UBERON:0000947
      label: aorta
  biological_processes:
  - preferred_term: renin-angiotensin regulation of aldosterone production
    term:
      id: GO:0002018
      label: renin-angiotensin regulation of aldosterone production
    modifier: INCREASED
  - preferred_term: positive regulation of vasoconstriction
    term:
      id: GO:0045907
      label: positive regulation of vasoconstriction
    modifier: INCREASED
  evidence:
  - reference: PMID:40283210
    reference_title: "Association of Plasma Renin Activity with Risk of Late Hypertension in Pediatric Patients with Early Aortic Coarctation Repair: A Retrospective Study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      preoperative renin plasma concentration above the upper normal level (46.1
      μUI/mL) was independently associated with the occurrence of hypertension
      (OR = 2.49, 95% CI = 2.001-5.03, p = 0.001).
    explanation: >-
      Quantifies preoperative renin as an independent predictor of postoperative
      hypertension, the claim that makes this node upstream of persistent rather
      than merely acute hypertension.
  - reference: PMID:40283210
    reference_title: "Association of Plasma Renin Activity with Risk of Late Hypertension in Pediatric Patients with Early Aortic Coarctation Repair: A Retrospective Study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The renin-angiotensin system plays a significant part in the etiology of
      vascular dysfunction in these patients, and several studies report
      increased preoperative and postoperative levels
    explanation: >-
      Supports renin-angiotensin activation both before and after repair.
  downstream:
  - target: Persistent Hypertension After Anatomic Repair
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      Neurohormonal priming established before repair persists after the gradient
      is abolished.
- name: Collateral Arterial Development
  biological_scale: TISSUE
  description: >
    Over months to years, flow bypasses the obstruction through enlarging
    intercostal, internal thoracic, and subscapular arteries. Collateralization is
    protective - it maintains distal perfusion and can render an anatomically
    severe coarctation clinically silent into adulthood - and is simultaneously
    the reason presentation is so often delayed until hypertension or a
    complication supervenes. The enlarged intercostal arteries erode the inferior
    rib margins, producing the classical radiographic notching.
  locations:
  - preferred_term: thoracic aorta
    term:
      id: UBERON:0001515
      label: thoracic aorta
  cell_types:
  - preferred_term: arterial endothelial cell
    term:
      id: CL:0000115
      label: endothelial cell
  evidence:
  - reference: PMID:40671984
    reference_title: "Hypertension Secondary to Severe Aortic Coarctation in an Adult Patient."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      CT angiography (CTA) confirmed a severe coarctation, with a minimal
      luminal diameter of 3 mm, located 38 mm distal to the left subclavian
      artery, and extensive collateral circulation via intercostal and internal
      mammary arteries.
    explanation: >-
      Documents the intercostal and internal mammary collateral network in a
      severe coarctation, the vessels this node asserts enlarge.
  - reference: PMID:40671984
    reference_title: "Hypertension Secondary to Severe Aortic Coarctation in an Adult Patient."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Chest X-ray revealed rib notching and the classic "3-sign," raising
      suspicion of aortic coarctation.
    explanation: >-
      Supports the radiographic rib notching produced by enlarged intercostal
      arteries.
  - reference: PMID:40671984
    reference_title: "Hypertension Secondary to Severe Aortic Coarctation in an Adult Patient."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A 42-year-old man with a 24-year history of poorly controlled hypertension
      was admitted following a traumatic femoral fracture.
    explanation: >-
      Supports the delayed-presentation claim: a severe coarctation went
      anatomically undiagnosed into the fifth decade, presenting only through its
      hypertensive consequence and then incidentally.
  downstream:
  - target: Persistent Hypertension After Anatomic Repair
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Collateralization delays diagnosis by preserving distal perfusion, so the
      obstruction and its neurohormonal consequences persist untreated for
      longer. The intermediates between duration of untreated obstruction and
      post-repair hypertension are not established, hence the weak edge typing.
- name: Ductal-Dependent Systemic Perfusion in Critical Coarctation
  biological_scale: ORGANISM
  description: >
    In the most severe form, the neonate is well while the ductus arteriosus is
    open because systemic flow below the coarctation is supplied right-to-left
    across it. Ductal closure in the first days of life abruptly removes that
    supply, producing shock, acidosis, and heart failure. The presentation is
    therefore timed by ductal physiology rather than by the anatomy, and it is
    reversible in the short term by reopening the ductus pharmacologically.
  locations:
  - preferred_term: ductus arteriosus
    term:
      id: UBERON:0005440
      label: ductus arteriosus
  evidence:
  - reference: PMID:10771966
    reference_title: "Prostaglandin E1: first stage palliation in neonates with congenital cardiac defects."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      lesions with ductus dependent systemic blood flow e.g. critical aortic
      stenosis, coarctation of aorta, interruption of aortic arch
    explanation: >-
      Classifies coarctation explicitly among the lesions with ductus-dependent
      systemic blood flow, the claim of this node.
- name: Left Ventricular Pressure Overload and Hypertrophy
  biological_scale: TISSUE
  description: >
    The left ventricle hypertrophies against the elevated afterload. Ventricular
    mass in repaired coarctation tracks ambulatory rather than clinic blood
    pressure, and the relationship is steeper than in healthy controls - the same
    daytime pressure buys more hypertrophy in a coarctation patient. Left
    ventricular mass is itself a predictor of late morbidity and mortality, so
    this node is not merely a marker of load.
  locations:
  - preferred_term: heart left ventricle
    term:
      id: UBERON:0002084
      label: heart left ventricle
  cell_types:
  - preferred_term: cardiomyocyte
    term:
      id: CL:0000746
      label: cardiac muscle cell
  evidence:
  - reference: PMID:12821257
    reference_title: "Ambulatory blood pressure, left ventricular mass, and conduit artery function late after successful repair of coarctation of the aorta."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Systolic BP at 24 h was an independent predictor of LV mass, having an
      accentuated impact in coarctation subjects as compared with controls.
    explanation: >-
      Supports both the pressure-mass relationship and its accentuation specific
      to coarctation.
  - reference: PMID:12821257
    reference_title: "Ambulatory blood pressure, left ventricular mass, and conduit artery function late after successful repair of coarctation of the aorta."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Patients had higher 24-h systolic BP and LV mass than controls.
    explanation: >-
      Documents hypertrophy in successfully repaired patients relative to healthy
      volunteers.
- name: Diffuse Arteriopathy of the Pre-Coarctation Vasculature
  biological_scale: TISSUE
  description: >
    The arteries proximal to the coarctation are intrinsically abnormal, not
    merely exposed to high pressure. In repaired patients both
    endothelium-dependent flow-mediated dilation and the response to the
    endothelium-independent smooth muscle dilator glyceryl trinitrate are
    reduced, and pulse wave velocity is increased - the second of those is the
    decisive observation, because a purely endothelial defect would spare the
    nitrate response. Arterial stiffness and endothelial dysfunction persist
    decades after early repair. This node is the reason coarctation is a systemic
    disease rather than a segmental one.
  locations:
  - preferred_term: aorta
    term:
      id: UBERON:0000947
      label: aorta
  cell_types:
  - preferred_term: arterial endothelial cell
    term:
      id: CL:0000115
      label: endothelial cell
  - preferred_term: arterial smooth muscle cell
    term:
      id: CL:0000359
      label: vascular associated smooth muscle cell
  evidence:
  - reference: PMID:12821257
    reference_title: "Ambulatory blood pressure, left ventricular mass, and conduit artery function late after successful repair of coarctation of the aorta."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Both endothelium-dependent FMD and the response to the smooth muscle
      dilator GTN were reduced, and PWV was increased.
    explanation: >-
      The core evidence that the abnormality is not confined to the endothelium:
      the endothelium-independent nitrate response is impaired too.
  - reference: PMID:28545853
    reference_title: "Elevated sympathetic activity, endothelial dysfunction, and late hypertension after repair of coarctation of the aorta."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      After coarctation repair patients have increased muscle sympathetic nerve
      activity, dampened sympathetic baroreflex response, endothelial
      dysfunction, and increased ambulatory arterial stiffness index
    explanation: >-
      Documents persistent endothelial dysfunction and arterial stiffening a
      median 26 years after repair, alongside autonomic abnormalities.
  downstream:
  - target: Persistent Hypertension After Anatomic Repair
    causal_link_type: DIRECT
    description: >-
      Stiff, poorly dilating conduit arteries raise systolic pressure
      independently of any residual obstruction.
  - target: Accelerated Atherosclerosis and Late Cardiovascular Mortality
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      Endothelial dysfunction and vascular wall abnormality are the substrate on
      which atherosclerotic disease accumulates prematurely.
- name: Elevated Sympathetic Outflow and Baroreflex Impairment
  biological_scale: ORGANISM
  description: >
    Directly measured muscle sympathetic nerve activity is elevated in repaired
    coarctation patients and the sympathetic baroreflex is dampened, while the
    cardiac baroreflex is preserved - a dissociation suggesting the abnormality
    lies in the arterial baroreceptor limb rather than in central autonomic
    control generally. Because the carotid and aortic baroreceptors sit in the
    abnormal proximal vasculature, this is plausibly the arteriopathy expressing
    itself through the autonomic nervous system rather than a separate lesion.
  evidence:
  - reference: PMID:28545853
    reference_title: "Elevated sympathetic activity, endothelial dysfunction, and late hypertension after repair of coarctation of the aorta."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Coarctation patients had elevated muscle sympathetic nerve activity
      compared with controls
    explanation: >-
      Direct measurement of elevated sympathetic outflow rather than an inference
      from blood pressure.
  - reference: PMID:28545853
    reference_title: "Elevated sympathetic activity, endothelial dysfunction, and late hypertension after repair of coarctation of the aorta."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      dampened sympathetic baroreflex function (-2.2±2.1 vs. -7.0±5.6
      bursts/100heartbeats·mm·Hg-1, p=0.007), normal cardiac baroreflex function
    explanation: >-
      Supports selective impairment of the sympathetic baroreflex limb, quoting
      it alongside the preserved cardiac baroreflex measured in the same
      patients. The dissociation is the point: a global autonomic lesion would
      have impaired both.
  downstream:
  - target: Persistent Hypertension After Anatomic Repair
    causal_link_type: DIRECT
    description: >-
      Elevated sympathetic tone with a blunted buffering reflex sustains
      hypertension after the gradient is removed.
- name: Persistent Hypertension After Anatomic Repair
  biological_scale: ORGANISM
  description: >
    Hypertension recurs or persists in a large fraction of patients despite a
    technically successful repair and no residual gradient - 58.5% at two years
    in a series repaired predominantly under one month of age. It is the
    convergence point of three upstream processes that repair does not touch:
    neurohormonal priming, the diffuse arteriopathy, and autonomic dysregulation.
    Patients with normal clinic pressures may still be hypertensive on ambulatory
    monitoring, so the phenotype is systematically under-detected by the
    measurement most clinics use.
  biological_processes:
  - preferred_term: regulation of blood pressure
    term:
      id: GO:0008217
      label: regulation of blood pressure
    modifier: ABNORMAL
  evidence:
  - reference: PMID:40283210
    reference_title: "Association of Plasma Renin Activity with Risk of Late Hypertension in Pediatric Patients with Early Aortic Coarctation Repair: A Retrospective Study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A follow-up at two years revealed an incidence of 58.5% of hypertension.
    explanation: >-
      Quantifies persistent hypertension after early repair, the central claim of
      this node.
  - reference: PMID:12821257
    reference_title: "Ambulatory blood pressure, left ventricular mass, and conduit artery function late after successful repair of coarctation of the aorta."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      patients with normal resting blood pressure (BP) may have hypertension
      during daily life and LV hypertrophy.
    explanation: >-
      Supports systematic under-detection of the hypertensive phenotype by clinic
      measurement.
  - reference: PMID:39926128
    reference_title: "Coarctation of the aorta and accelerated atherosclerosis: A contemporary review on the burden of atherosclerotic cardiovascular disease."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      there is a high prevalence of hypertension and late cardiovascular
      mortality in patients with CoA despite successful repair.
    explanation: >-
      States the persistence of hypertension despite successful repair. Evidence
      source is OTHER because this is a review.
  downstream:
  - target: Left Ventricular Pressure Overload and Hypertrophy
    causal_link_type: DIRECT
    description: >-
      Sustained systemic hypertension continues to load the ventricle after the
      obstruction is gone.
  - target: Accelerated Atherosclerosis and Late Cardiovascular Mortality
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      Chronic hypertension is a principal driver of the premature atherosclerotic
      burden in this population.
- name: Accelerated Atherosclerosis and Late Cardiovascular Mortality
  biological_scale: ORGANISM
  description: >
    Repaired coarctation patients accumulate coronary artery disease, coronary
    and aortic calcium, stroke, and peripheral arterial disease earlier than
    expected, and late cardiovascular mortality remains high. This is the
    endpoint that makes the entry's framing necessary: it is not a complication
    of the operation, it is what the arteriopathy does over decades while the
    repaired anatomy looks normal. The burden is growing in absolute terms as the
    adult congenital heart disease population expands and ages.
  evidence:
  - reference: PMID:39926128
    reference_title: "Coarctation of the aorta and accelerated atherosclerosis: A contemporary review on the burden of atherosclerotic cardiovascular disease."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      the prevalence of atherosclerosis and associated sequelae in repaired CoA
      including coronary artery disease, coronary artery calcium, aortic calcium,
      stroke, and peripheral artery disease
    explanation: >-
      Enumerates the atherosclerotic sequelae asserted by this node. Evidence
      source is OTHER because this is a contemporary review.
  - reference: PMID:39926128
    reference_title: "Coarctation of the aorta and accelerated atherosclerosis: A contemporary review on the burden of atherosclerotic cardiovascular disease."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      The growing impact of acquired cardiovascular disease remains a significant
      concern as the adult congenital heart disease population continues to
      rapidly expand and age.
    explanation: >-
      Supports the growing absolute burden claim.
  - reference: PMID:40283210
    reference_title: "Association of Plasma Renin Activity with Risk of Late Hypertension in Pediatric Patients with Early Aortic Coarctation Repair: A Retrospective Study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      the occurrence of postoperative hypertension associated with cardiovascular
      and cerebral vascular disease increases mortality and morbidity in the long
      term.
    explanation: >-
      Links postoperative hypertension to long-term cardiovascular and
      cerebrovascular mortality.
phenotypes:
- category: Cardiovascular
  name: Coarctation of Aorta
  description: >
    Congenital narrowing of the thoracic aorta at the isthmus, the defining
    lesion.
  phenotype_term:
    preferred_term: Coarctation of aorta
    term:
      id: HP:0001680
      label: Coarctation of aorta
  evidence:
  - reference: PMID:29590334
    reference_title: "A rare missense mutation in MYH6 associates with non-syndromic coarctation of the aorta."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Coarctation of the aorta (CoA) accounts for 4-8% of congenital heart
      defects (CHDs) and confers substantial morbidity despite treatment.
    explanation: >-
      Establishes the lesion and its share of congenital heart disease.
- category: Cardiovascular
  name: Hypertension
  description: >
    Upper-body systolic hypertension before repair, and persistent or recurrent
    hypertension after it, present in a majority of patients within two years of
    early repair.
  phenotype_term:
    preferred_term: Hypertension
    term:
      id: HP:0000822
      label: Hypertension
  frequency: FREQUENT
  evidence:
  - reference: PMID:40283210
    reference_title: "Association of Plasma Renin Activity with Risk of Late Hypertension in Pediatric Patients with Early Aortic Coarctation Repair: A Retrospective Study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A follow-up at two years revealed an incidence of 58.5% of hypertension.
    explanation: >-
      Quantifies hypertension frequency after early repair, supporting the
      FREQUENT band.
- category: Cardiovascular
  name: Bicuspid Aortic Valve
  description: >
    A two-leaflet aortic valve, present in more than half of coarctation cases
    and the commonest associated lesion.
  phenotype_term:
    preferred_term: Bicuspid aortic valve
    term:
      id: HP:0001647
      label: Bicuspid aortic valve
  frequency: FREQUENT
  evidence:
  - reference: PMID:24418111
    reference_title: "Variants in the NOTCH1 gene in patients with aortic coarctation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In more than half of the cases, coarctation was combined with bicuspid
      aortic valve
    explanation: >-
      Directly quantifies the association in a consecutive coarctation series,
      supporting the FREQUENT band.
- category: Cardiovascular
  name: Left Ventricular Hypertrophy
  description: >
    Increased left ventricular mass driven by afterload, present even in
    successfully repaired patients and predictive of late morbidity.
  phenotype_term:
    preferred_term: Left ventricular hypertrophy
    term:
      id: HP:0001712
      label: Left ventricular hypertrophy
  evidence:
  - reference: PMID:12821257
    reference_title: "Ambulatory blood pressure, left ventricular mass, and conduit artery function late after successful repair of coarctation of the aorta."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Patients had higher 24-h systolic BP and LV mass than controls.
    explanation: >-
      Documents increased ventricular mass in repaired coarctation versus healthy
      controls.
- category: Cardiovascular
  name: Ventricular Septal Defect
  description: >
    A common associated intracardiac lesion, and on the flow account one of the
    fetal shunts that reduces antegrade isthmic flow.
  phenotype_term:
    preferred_term: Ventricular septal defect
    term:
      id: HP:0001629
      label: Ventricular septal defect
- category: Cardiovascular
  name: Cardiogenic Shock
  description: >
    Abrupt circulatory collapse in the neonate with critical coarctation when the
    ductus arteriosus closes and ductal-dependent systemic perfusion is lost.
  phenotype_term:
    preferred_term: Cardiogenic shock
    term:
      id: HP:0030149
      label: Cardiogenic shock
    temporality: ACUTE
  evidence:
  - reference: PMID:10771966
    reference_title: "Prostaglandin E1: first stage palliation in neonates with congenital cardiac defects."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      lesions with ductus dependent systemic blood flow e.g. critical aortic
      stenosis, coarctation of aorta, interruption of aortic arch
    explanation: >-
      Supports coarctation as a ductus-dependent systemic-flow lesion, the
      physiology whose interruption produces neonatal shock.
- category: Cardiovascular
  name: Cerebral Berry Aneurysm
  description: >
    Intracranial berry aneurysms occur with increased frequency, a further
    manifestation of the systemic arteriopathy rather than of the aortic
    obstruction.
  phenotype_term:
    preferred_term: Cerebral berry aneurysm
    term:
      id: HP:0007029
      label: Cerebral berry aneurysm
  notes: >
    No `frequency` band is asserted. The association is well described
    clinically, but no source cited in this entry quantifies it, and a frequency
    band is a separate quantitative claim from the association itself. Per the
    project's frequency-evidence guidance, the band is omitted rather than
    guessed.
mechanistic_hypotheses:
- hypothesis_group_id: ductal_tissue_migration
  hypothesis_label: Ectopic ductal tissue constriction
  status: CANONICAL
  description: >
    Contractile tissue of ductus arteriosus type extends ectopically into the
    aortic isthmus; when the ductus constricts after birth, the ectopic tissue
    contracts with it and draws in the aortic wall. This is the traditional
    account and explains the juxtaductal location of the shelf and the timing of
    neonatal decompensation at ductal closure. It predicts that the narrowing is
    an active, tissue-intrinsic constriction rather than a growth failure. The
    PRDM6 association - a smooth-muscle-specific transcription factor causal for
    patent ductus arteriosus and reported in patients who also have coarctation -
    is the most direct contemporary support for a shared ductal/aortic
    smooth-muscle lesion, though it falls short of demonstrating the ectopic
    tissue itself.
  evidence:
  - reference: PMID:7057615
    reference_title: "Angiocardiographic study of coarctation of the aorta--morphology and morphogenesis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      localized stenosis is related to abnormal distribution of the ductal tissue
      to the descending aorta and post-natal constriction of the ductus
      arteriosus.
    explanation: >-
      States this hypothesis in the terms curated here, as the account of the
      localized stenosis component specifically.
  - reference: PMID:38071433
    reference_title: "Patent ductus arteriosus and coarctation of the aorta in association with PRDM6 variants."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Pathogenic variants in PRDM6, which encodes a smooth-muscle-cell-specific
      transcription factor, have now been etiologically associated with
      non-syndromic PDA.
    explanation: >-
      Supports a shared smooth-muscle-identity lesion linking the ductus and the
      aortic phenotype. Graded INDIRECT because it does not demonstrate ectopic
      ductal tissue in the isthmus.
- hypothesis_group_id: reduced_fetal_flow
  hypothesis_label: Reduced fetal isthmic flow
  status: ALTERNATIVE
  description: >
    Any fetal lesion diverting blood from the ascending aorta and arch reduces
    antegrade flow through the isthmus, which then fails to grow. This predicts
    exactly the clustering that is observed - coarctation with bicuspid or
    stenotic aortic valve, with ventricular septal defect, with arch or
    descending aortic hypoplasia - and predicts that isolated coarctation should
    be the exception rather than the rule. It is the same reasoning applied to
    hypoplastic left heart syndrome, and it shares that debate's central
    difficulty: the association is compatible with reduced flow causing the
    hypoplasia and with a shared developmental lesion causing both.
  evidence:
  - reference: PMID:7057615
    reference_title: "Angiocardiographic study of coarctation of the aorta--morphology and morphogenesis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      ischemic hypoplasia results from prenatal decrease of blood flow to the
      ascending aorta
    explanation: >-
      States this hypothesis in the terms curated here, as the account of the
      hypoplastic component specifically.
  - reference: PMID:24418111
    reference_title: "Variants in the NOTCH1 gene in patients with aortic coarctation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      in approximately half of the cases, it was combined with hypoplasia of the
      aortic arch or descending aorta.
    explanation: >-
      Documents the coexisting arch and descending aortic hypoplasia that the
      flow account predicts.
  - reference: PMID:33432820
    reference_title: "Genetic Etiology of Left-Sided Obstructive Heart Lesions: A Story in Development."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      only 16.2% of patients with CoA have isolated disease, whereas the majority
      have concomitant cardiac defects.
    explanation: >-
      The population-level prediction of this hypothesis, quantified: if
      coarctation arises because some other lesion diverted fetal flow, isolated
      coarctation should be the exception. It is - by a factor of five. Evidence
      source is OTHER because this is a narrative review.
treatments:
- name: Surgical Coarctation Repair
  description: >
    Resection of the coarctation segment with extended end-to-end anastomosis, or
    equivalent surgical reconstruction. Reliably abolishes the gradient. Earlier
    repair reduces but does not eliminate the risk of late hypertension.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: surgical procedure
    term:
      id: NCIT:C15329
      label: Surgical Procedure
  target_mechanisms:
  - target: Fixed Aortic Obstruction and Pressure Gradient
    treatment_effect: INHIBITS
    description: >-
      Excising the narrowed segment removes the fixed resistance and the
      proximal-to-distal pressure gradient.
  evidence:
  - reference: PMID:40283210
    reference_title: "Association of Plasma Renin Activity with Risk of Late Hypertension in Pediatric Patients with Early Aortic Coarctation Repair: A Retrospective Study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In all except two patients, end-to-end anastomosis was used.
    explanation: >-
      Documents end-to-end anastomosis as the operative technique in the cited
      early-repair cohort.
  - reference: PMID:40283210
    reference_title: "Association of Plasma Renin Activity with Risk of Late Hypertension in Pediatric Patients with Early Aortic Coarctation Repair: A Retrospective Study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Early repair of CoA, especially under one year of life, and extended
      end-to-end anastomosis are reported to reduce the risk of development of HT
      later in life
    explanation: >-
      Supports a benefit of early repair on late hypertension. Graded PARTIAL
      because the same cohort still had 58.5% hypertension at two years despite
      repair under one month in most patients - the reduction is real and clearly
      incomplete.
- name: Balloon Angioplasty and Endovascular Stenting
  description: >
    Catheter-based dilation of the coarctation segment, with or without stent
    implantation. Avoids thoracotomy and is the usual approach to recoarctation
    and to older patients.
  therapeutic_modality: DEVICE
  treatment_term:
    preferred_term: balloon angioplasty
    term:
      id: NCIT:C93007
      label: Balloon Angioplasty
  target_mechanisms:
  - target: Fixed Aortic Obstruction and Pressure Gradient
    treatment_effect: INHIBITS
    description: >-
      Mechanical dilation enlarges the stenotic lumen and relieves the gradient.
  evidence:
  - reference: PMID:40283210
    reference_title: "Association of Plasma Renin Activity with Risk of Late Hypertension in Pediatric Patients with Early Aortic Coarctation Repair: A Retrospective Study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Surgery and interventional methods offer great short-term results
    explanation: >-
      Groups interventional (catheter-based) with surgical relief as effective in
      the short term.
- name: Prostaglandin E1 Infusion
  description: >
    Continuous intravenous alprostadil to maintain or reopen ductal patency in
    the neonate with critical coarctation, restoring ductal-dependent systemic
    perfusion as a bridge to definitive repair. It does not treat the coarctation;
    it buys time by preventing the physiologic event that unmasks it.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: prostaglandin E1
      term:
        id: CHEBI:15544
        label: prostaglandin E1
  target_mechanisms:
  - target: Ductal-Dependent Systemic Perfusion in Critical Coarctation
    treatment_effect: ACTIVATES
    description: >-
      Maintaining ductal patency preserves right-to-left flow supplying the body
      below the coarctation.
  evidence:
  - reference: PMID:10771966
    reference_title: "Prostaglandin E1: first stage palliation in neonates with congenital cardiac defects."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      E-type prostaglandins (PGE1) can effectively maintain the patency of the
      ductus arteriosus in neonates.
    explanation: >-
      Establishes the pharmacologic mechanism this treatment relies on.
  - reference: PMID:10771966
    reference_title: "Prostaglandin E1: first stage palliation in neonates with congenital cardiac defects."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      It helps in stabilizing these patients prior to further surgical palliation
      or correction.
    explanation: >-
      Supports the bridging role rather than a definitive one.
- name: Antihypertensive Therapy
  description: >
    Long-term blood pressure control after repair. Because a majority of patients
    become hypertensive again and the hypertension drives the late atherosclerotic
    burden, this is arguably the definitive treatment of the systemic disease -
    the operation treats the segment.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: antihypertensive therapy
    term:
      id: NCIT:C172184
      label: Antihypertensive Therapy
  target_mechanisms:
  - target: Persistent Hypertension After Anatomic Repair
    treatment_effect: INHIBITS
    description: >-
      Pharmacologic pressure reduction addresses the residual hypertensive
      phenotype that repair leaves behind.
  evidence:
  - reference: PMID:39926128
    reference_title: "Coarctation of the aorta and accelerated atherosclerosis: A contemporary review on the burden of atherosclerotic cardiovascular disease."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      This review aims to guide optimization of long-term cardiovascular health
      to ultimately reduce mortality and morbidity in this young high-risk
      population.
    explanation: >-
      Supports long-term cardiovascular risk management as the therapeutic aim
      after repair. Evidence source is OTHER because this is a review.
discussions:
- discussion_id: coa_morphogenesis_ductal_vs_flow
  kind: CONTROVERSY
  attaches_to:
  - "pathophysiology#Ectopic Ductal Tissue at the Aortic Isthmus"
  - "pathophysiology#Reduced Antegrade Flow Through the Fetal Aortic Isthmus"
  prompt: >
    Does the isthmic narrowing arise from constriction of ectopic ductal tissue,
    from failure of an underperfused isthmus to grow, or from both in different
    patients?
  rationale: >
    The two accounts predict different things about what repair can achieve. If
    the lesion is an active constriction of misplaced ductal muscle, the aorta
    proximal and distal to it may be structurally normal and complete excision
    should be curative. If the isthmus failed to grow because it was
    underperfused, the whole left-heart-and-arch complex is developmentally
    abnormal and the narrowing is one visible part of a larger lesion. The
    persistence of hypertension and arteriopathy after technically perfect repair
    is easier to reconcile with the second, but does not settle it, because a
    shared genetic program could produce both the ductal-tissue anomaly and the
    arterial wall abnormality independently. Contemporary genetics is
    uncomfortable for a clean separation: PRDM6 is a smooth-muscle-identity gene
    implicated in the ductal lesion, while MYH6 and NOTCH1 sit in the
    outflow-tract program that the flow account invokes.
  evidence:
  - reference: PMID:7057615
    reference_title: "Angiocardiographic study of coarctation of the aorta--morphology and morphogenesis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      ischemic hypoplasia results from prenatal decrease of blood flow to the
      ascending aorta, and localized stenosis is related to abnormal distribution
      of the ductal tissue to the descending aorta and post-natal constriction of
      the ductus arteriosus.
    explanation: >-
      The clearest statement that both accounts are needed - one for the
      hypoplastic component and one for the localized stenosis. Graded PARTIAL
      because the authors present it explicitly as a working hypothesis
      compatible with their angiographic findings, not as a demonstrated
      morphogenesis.
  proposed_experiments:
  - experiment_id: exp_coa_isthmic_flow_fetal_imaging
    name: Prospective fetal flow measurement in isthmic narrowing
    description: >-
      Serially quantify antegrade isthmic flow by fetal echocardiography in
      pregnancies at risk of coarctation, and relate flow trajectory to postnatal
      isthmic dimensions and to the presence of a discrete posterior shelf. A
      shelf appearing in fetuses with preserved isthmic flow would support the
      ductal-tissue account; progressive isthmic hypoplasia tracking with falling
      flow would support the growth-failure account.
  - experiment_id: exp_coa_resected_segment_histology_genotype
    name: Histologic and transcriptional characterization of resected coarctation segments by genotype
    description: >-
      Characterize resected coarctation segments for ductal-type smooth muscle
      markers and compare across genotype strata (PRDM6, MYH6, NOTCH1 variant
      carriers versus non-carriers). Enrichment of ductal-type tissue in PRDM6
      carriers specifically would connect the genetic and morphogenetic accounts
      rather than leaving them as parallel narratives.
- discussion_id: coa_arteriopathy_intrinsic_vs_acquired
  kind: KNOWLEDGE_GAP
  attaches_to:
  - "pathophysiology#Diffuse Arteriopathy of the Pre-Coarctation Vasculature"
  prompt: >
    Is the arteriopathy of the pre-coarctation vasculature developmentally
    intrinsic, or acquired from years of exposure to elevated proximal pressure?
  rationale: >
    This determines whether earlier repair can prevent it or only limit it. The
    evidence points both ways. Abnormality of the endothelium-independent
    nitrate response argues for a structural, and plausibly intrinsic, wall
    defect rather than a purely functional consequence of hypertension. But the
    same abnormalities are documented in patients repaired in the first months of
    life and followed for decades, so exposure duration was already minimal and
    the abnormality persisted - which is consistent with an intrinsic defect and
    equally consistent with an irreversible early insult. No study has compared
    pre-coarctation arterial structure in fetuses or neonates before any
    significant pressure exposure has occurred.
  proposed_experiments:
  - experiment_id: exp_coa_neonatal_arterial_wall_before_exposure
    name: Arterial wall characterization in neonates before significant pressure exposure
    description: >-
      Measure proximal arterial stiffness and endothelium-dependent and
      -independent function in neonates with prenatally diagnosed coarctation
      before repair and before prolonged hypertensive exposure, comparing with
      matched controls. Abnormality already present at this point would establish
      the arteriopathy as intrinsic rather than acquired.
- discussion_id: coa_atherogenesis_module_conformance
  kind: CURATION_TODO
  attaches_to:
  - "pathophysiology#Accelerated Atherosclerosis and Late Cardiovascular Mortality"
  prompt: >
    Should the accelerated-atherosclerosis node declare conformance to the
    `atherogenesis` module?
  rationale: >
    Mechanistically it very likely should. The module's core chain is apoB
    lipoprotein retention at a dysfunctional endothelium, foam-cell formation,
    and smooth-muscle-cell fibrofatty plaque assembly, and repaired coarctation
    supplies exactly the endothelial dysfunction and hypertensive substrate that
    chain begins from. What is missing is evidence: the source cited here is a
    review reporting the prevalence of atherosclerotic sequelae in this
    population, which establishes that plaques accumulate faster, not that they
    are assembled by the module's mechanism in these patients specifically.
    Declaring conformance on that basis would assert mechanism from epidemiology.
    Left as an explicit curation task rather than a silent omission.
inheritance:
- name: Multifactorial (polygenic) inheritance
  inheritance_term:
    preferred_term: Polygenic inheritance
    term:
      id: HP:0010982
      label: Polygenic inheritance
  description: >
    Coarctation sits within the left-sided obstructive lesion spectrum, which is
    clearly heritable - nonsyndromic defects recur in families and carry a high
    sibling recurrence risk - without following a Mendelian pattern. The
    currently accepted genes for this spectrum explain only 10-20% of patients,
    and the emerging picture is combinatorial: common and rare variants acting
    together. That is why the three genes curated below are all typed
    SUSCEPTIBILITY rather than causative, despite NOTCH1 and MYH6 being
    well-replicated associations.
  evidence:
  - reference: PMID:33432820
    reference_title: "Genetic Etiology of Left-Sided Obstructive Heart Lesions: A Story in Development."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      nonsyndromic defects are often observed in multiple family members and
      associated with high sibling recurrence risk. This clear evidence for a
      heritable basis has driven a lengthy search for disease-causing variants
    explanation: >-
      Establishes familial recurrence and a heritable basis for the left-sided
      obstructive lesion spectrum that includes coarctation.
  - reference: PMID:33432820
    reference_title: "Genetic Etiology of Left-Sided Obstructive Heart Lesions: A Story in Development."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      the currently accepted LSOL-associated genes explain only 10% to 20% of
      patients. Further, the combinatorial effects of common and rare variants as
      a cause of LSOLs are emerging.
    explanation: >-
      Quantifies the unexplained majority and supports a combinatorial rather
      than Mendelian architecture, which is what justifies a polygenic record.
      Evidence source is OTHER because this is a narrative review, matching how
      the other review cited in this entry is classified.
  - reference: PMID:33432820
    reference_title: "Genetic Etiology of Left-Sided Obstructive Heart Lesions: A Story in Development."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      The risk of CHD varies by the proband's defect but is higher than the
      general population with prevalence in first‐degree relatives of 19% for
      HLHS, 9% for CoA, and 1% for transposition of the great arteries.
    explanation: >-
      Quantifies familial aggregation stratified by proband defect. Note what the
      9% figure does and does not measure: it is the prevalence of *any*
      congenital heart defect among first-degree relatives of a coarctation
      proband, not recurrence of coarctation itself. That distinction matters
      here rather than being pedantic - a familial excess of heterogeneous
      left-sided lesions is what a shared developmental program predicts, and is
      weaker evidence for a coarctation-specific recurrence risk than the raw
      number suggests. Evidence source is OTHER because this is a narrative
      review.
  - reference: PMID:33432820
    reference_title: "Genetic Etiology of Left-Sided Obstructive Heart Lesions: A Story in Development."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Family studies demonstrate a heritable factor for CoA; however,
      ascertaining the genetics of CoA is difficult because only 16.2% of
      patients with CoA have isolated disease, whereas the majority have
      concomitant cardiac defects.
    explanation: >-
      Coarctation-specific heritability, plus the methodological caveat that
      makes its genetics hard to resolve. The 16.2%-isolated figure does double
      duty: it is also the strongest population-level observation favouring the
      reduced-fetal-flow account, which predicts exactly this clustering with
      other left-heart lesions. Evidence source is OTHER because this is a
      narrative review.
diagnosis:
- name: Four-Limb Blood Pressure Gradient
  description: >
    The bedside finding that makes the diagnosis: a systolic pressure difference
    between upper and lower limbs, with diminished or delayed femoral pulses.
    It is also the finding most often not looked for - a severe coarctation can
    sit behind two decades of "poorly controlled hypertension" until someone
    compares an arm with a leg.
  diagnosis_term:
    preferred_term: blood pressure measurement
    term:
      id: NCIT:C167233
      label: Blood Pressure Measurement
  evidence:
  - reference: PMID:40671984
    reference_title: "Hypertension Secondary to Severe Aortic Coarctation in an Adult Patient."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Cardiovascular evaluation was prompted by a 25 mmHg systolic blood
      pressure difference between the left upper limb (165/90 mmHg) and the left
      lower limb (140/85 mmHg), along with an interscapular systolic murmur,
      during trauma admission, suggesting coarctation.
    explanation: >-
      Documents the upper-to-lower limb gradient and interscapular murmur
      prompting the diagnosis, in a patient hypertensive for 24 years
      beforehand.
- name: Transthoracic Echocardiography
  description: >
    First-line imaging, which localizes the obstruction and quantifies its
    severity by the transisthmic gradient, while also assessing the associated
    intracardiac lesions - above all the bicuspid aortic valve present in more
    than half of cases.
  diagnosis_term:
    preferred_term: echocardiography
    term:
      id: NCIT:C16525
      label: Echocardiography Test
  evidence:
  - reference: PMID:40671984
    reference_title: "Hypertension Secondary to Severe Aortic Coarctation in an Adult Patient."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Transthoracic echocardiography (TTE) showed no intracardiac deformity and
      demonstrated a peak-to-peak gradient of 60 mmHg across the aortic isthmus.
    explanation: >-
      Documents echocardiographic quantification of the isthmic gradient and
      exclusion of associated intracardiac lesions.
- name: CT Angiography
  description: >
    Cross-sectional angiography defines the anatomy that determines the repair
    strategy - the length and minimal diameter of the narrowed segment, its
    distance from the left subclavian artery, and the extent of the collateral
    network.
  diagnosis_term:
    preferred_term: computed tomography angiography
    term:
      id: NCIT:C202408
      label: Computed Tomography Angiography
  evidence:
  - reference: PMID:40671984
    reference_title: "Hypertension Secondary to Severe Aortic Coarctation in an Adult Patient."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      CT angiography (CTA) confirmed a severe coarctation, with a minimal
      luminal diameter of 3 mm, located 38 mm distal to the left subclavian
      artery, and extensive collateral circulation via intercostal and internal
      mammary arteries.
    explanation: >-
      Documents the anatomic detail CT angiography supplies and that it drove a
      staged endovascular approach in this case.
prevalence:
- population: Metropolitan Atlanta live births, 1970-1983
  measure_type: BIRTH_PREVALENCE
  prevalence_class: BAND_1_5_PER_10000
  rate_per_100000: 36.2
  notes: >-
    3.62 per 10,000 live births in a population-based birth defects registry
    (131 coarctation cases). Reported alongside aortic arch interruption (0.50)
    and aortic hypoplasia (0.58) per 10,000.
  evidence:
  - reference: PMID:2274893
    reference_title: "Descriptive epidemiology of selected malformations of the aorta, Atlanta, 1970-1983."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The prevalence per 10,000 live births was as follows: interruption of the
      aortic arch, 0.50; coarctation, 3.62; and hypoplasia of the aorta, 0.58.
    explanation: >-
      Population-based birth prevalence for coarctation specifically,
      distinguished from the neighbouring obstructive arch malformations.
animal_models:
- name: Rat suprarenal aortic banding model
  species: Rattus norvegicus
  genotype: Wild-type Sprague-Dawley rat with surgical abdominal aortic banding above the renal arteries
  category: Induced (surgical) coarctation model
  publication: PMID:16280280
  modeled_mechanisms:
  - target: Renin-Angiotensin System Activation
    relationship: RECAPITULATES
    fidelity: HIGH
    description: >-
      Banding above the renal arteries places the kidneys in the low-pressure
      compartment, reproducing the renal hypoperfusion that drives renin release
      in human coarctation. This is the mechanism the model exists to isolate.
    evidence:
    - reference: PMID:16280280
      reference_title: "Hypertension induced by aortic coarctation above the renal arteries is associated with immune cell infiltration of the kidneys."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        renal hypoperfusion and the consequent activation of renin-angiotensin
        system may mediate this process by promoting local induction of
        chemoattractant and inflammatory cytokines.
      explanation: >-
        States the renal-hypoperfusion to renin-angiotensin sequence directly,
        which is the node this link claims the model recapitulates. Evidence
        source is MODEL_ORGANISM because this is a rat surgical model.
  - target: Fixed Aortic Obstruction and Pressure Gradient
    relationship: PARTIALLY_RECAPITULATES
    fidelity: MODERATE
    limitations: >-
      The obstruction is surgical and abdominal, not a juxtaductal isthmic
      lesion. It reproduces the haemodynamic geometry - severe hypertension
      proximal, normotension distal - while saying nothing about how the human
      narrowing forms. Neither curated morphogenetic hypothesis is testable in
      this model.
    description: >-
      A fixed aortic obstruction with the kidneys distal to it, matching the
      human pressure distribution.
    evidence:
    - reference: PMID:16280280
      reference_title: "Hypertension induced by aortic coarctation above the renal arteries is associated with immune cell infiltration of the kidneys."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        abdominal aorta coarctation (banding) above renal arteries, which causes
        severe HTN proximal but not distal to coarctation.
      explanation: >-
        Confirms the haemodynamic geometry is reproduced - severe hypertension
        proximal, normotension distal. Graded PARTIAL because the obstruction is
        surgical and abdominal rather than a juxtaductal isthmic lesion, so the
        pressure distribution matches while the lesion does not. Evidence source
        is MODEL_ORGANISM because this is a rat surgical model.
  - target: Diffuse Arteriopathy of the Pre-Coarctation Vasculature
    relationship: FAILS_TO_RECAPITULATE
    fidelity: LOW
    limitations: >-
      An acutely banded normal aorta has no developmental arteriopathy. Since the
      persistence of hypertension after repair in patients is attributed largely
      to that intrinsic vascular abnormality, this model cannot address the
      entry's central claim - and recording that explicitly is the point of
      including the link.
    description: >-
      Recorded as a negative link so the model is not read as validating the
      systemic-arteriopathy arm of this entry.
    evidence:
    - reference: PMID:16280280
      reference_title: "Hypertension induced by aortic coarctation above the renal arteries is associated with immune cell infiltration of the kidneys."
      supports: NO_EVIDENCE
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Sprague-Dawley rats with abdominal aorta coarctation (banding) above
        renal arteries, which causes severe HTN proximal but not distal to
        coarctation.
      explanation: >-
        Substantiates the negative claim by establishing what the model actually
        is: an acute surgical band applied to a wild-type vessel. There is no
        developmental arteriopathy to recapitulate and none is reported anywhere
        in the paper, which is why the grading is NO_EVIDENCE rather than REFUTE
        - the study does not test the question, and absence of a finding in a
        study that never looked is not a refutation. Evidence source is
        MODEL_ORGANISM because this is a rat surgical model.
  description: >
    Surgical banding of the abdominal aorta above the renal arteries reproduces
    the defining haemodynamic geometry of human coarctation: severe hypertension
    proximal to the obstruction, with the kidneys sitting distal to it. That is
    precisely the arrangement that drives renin-angiotensin activation in
    patients, and it is why this model bears on the renin node of this entry.
    Its limit is equally clear and worth stating: the band is surgical, so the
    model recapitulates the consequence of the obstruction and says nothing about
    either competing account of how the isthmus narrows. It is not a model of
    coarctation morphogenesis and should not be cited as one.
  evidence:
  - reference: PMID:16280280
    reference_title: "Hypertension induced by aortic coarctation above the renal arteries is associated with immune cell infiltration of the kidneys."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      We studied activation of peripheral blood leukocytes and cellular
      infiltration in the kidneys of Sprague-Dawley rats with abdominal aorta
      coarctation (banding) above renal arteries, which causes severe HTN
      proximal but not distal to coarctation.
    explanation: >-
      Establishes the model and confirms it reproduces the
      proximal-hypertension, distal-normotension geometry of human coarctation.
      Evidence source is MODEL_ORGANISM because this is a rat surgical model.
genetic:
- name: MYH6
  gene_term:
    preferred_term: MYH6
    term:
      id: hgnc:7576
      label: MYH6
  relationship_type: SUSCEPTIBILITY
  notes: >
    A rare MYH6 p.Arg721Trp variant identified by genome-wide association in
    Iceland is carried by approximately 20% of coarctation cases there and also
    associates with bicuspid aortic valve.
  evidence:
  - reference: PMID:29590334
    reference_title: "A rare missense mutation in MYH6 associates with non-syndromic coarctation of the aorta."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Approximately 20% of individuals with CoA in Iceland carry this mutation.
    explanation: >-
      Quantifies the variant's carrier frequency among coarctation cases in the
      studied population.
- name: NOTCH1
  gene_term:
    preferred_term: NOTCH1
    term:
      id: hgnc:7881
      label: NOTCH1
  relationship_type: SUSCEPTIBILITY
  notes: >
    NOTCH1 variation recurs across the left ventricular outflow tract
    malformation spectrum. A targeted screen found the R1279H substitution
    overrepresented in coarctation patients relative to controls.
  evidence:
  - reference: PMID:24418111
    reference_title: "Variants in the NOTCH1 gene in patients with aortic coarctation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      This variant was significantly overrepresented in the patients with aortic
      coarctation compared with those in the control group
    explanation: >-
      Supports an association from a single targeted screen; graded PARTIAL
      because the variant was also present in controls and the study was small.
- name: PRDM6
  gene_term:
    preferred_term: PRDM6
    term:
      id: hgnc:9350
      label: PRDM6
  relationship_type: SUSCEPTIBILITY
  notes: >
    PRDM6 encodes a smooth-muscle-cell-specific transcription factor
    etiologically associated with non-syndromic patent ductus arteriosus, and
    reported in patients presenting with both patent ductus arteriosus and
    coarctation.
  evidence:
  - reference: PMID:38071433
    reference_title: "Patent ductus arteriosus and coarctation of the aorta in association with PRDM6 variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We present three patients with PDA and CoA
    explanation: >-
      Supports co-occurrence of both lesions in PRDM6 variant carriers; graded
      PARTIAL because three patients do not establish PRDM6 as a coarctation
      gene.
epidemiology:
- name: Share of congenital heart disease
  description: >
    Coarctation accounts for roughly 4-8% of congenital heart defects.
  evidence:
  - reference: PMID:29590334
    reference_title: "A rare missense mutation in MYH6 associates with non-syndromic coarctation of the aorta."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Coarctation of the aorta (CoA) accounts for 4-8% of congenital heart
      defects (CHDs)
    explanation: >-
      Direct statement of the lesion's share of congenital heart disease.
- name: Coarctation and bicuspid aortic valve in Turner syndrome
  description: >
    In non-mosaic 45,X Turner syndrome assessed by cardiac MRI, aortic
    coarctation was present in 12.5% and bicuspid aortic valve in 34%.
  evidence:
  - reference: PMID:23825392
    reference_title: "Bicuspid aortic valve and aortic coarctation are linked to deletion of the X chromosome short arm in Turner syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Bicuspid aortic valves (BAV) were found in 52/152 (34%) 45,X study subjects
      and aortic coarctation (COA) in 19/152 (12.5%).
    explanation: >-
      Quantifies both lesions in a large karyotyped Turner syndrome cohort.
📚

References & Deep Research

Deep Research

1
Claude Code ▸
Coarctation of the Aorta: Comprehensive Disease Characteristics Research Report
claude-haiku-4-5-20251001, claude-sonnet-5 3 citations 2026-08-10T14:12:19.651513

Coarctation of the Aorta: Comprehensive Disease Characteristics Research Report

1. Disease Information

Overview. Coarctation of the aorta (CoA) is a congenital cardiovascular malformation characterized by a discrete (or, less commonly, long-segment/tubular) narrowing of the aortic lumen, most typically located at the aortic isthmus — the short segment of the descending thoracic aorta between the origin of the left subclavian artery and the site of insertion of the ductus arteriosus. Orphanet describes it as "a rare, non-syndromic, congenital heart malformation characterized by a narrowing of the proximal thoracic aorta, most commonly occurring after the origin of the brachiocephalic vessels" (Orphanet ORPHA:1457). It can occur as an isolated ("simple") anomaly or in combination with other left heart obstructive lesions (bicuspid aortic valve, mitral valve anomalies, subaortic stenosis, ventricular septal defect) as part of a "Shone complex" spectrum, and it is one of the left ventricular outflow tract malformations (LVOTO) that overlap mechanistically and genetically with hypoplastic left heart syndrome (HLHS) and interrupted aortic arch (IAA).

Key identifiers: - OMIM: 120000 (Coarctation of Aorta) — OMIM 120000 - Orphanet: ORPHA:1457 — Orphanet: Coarctation of aorta - MONDO: MONDO:0007345 - ICD-10-CM: Q25.1 (Coarctation of aorta) — ICD10Data Q25.1 - ICD-11: LA8B.21 - MeSH: D001017 (Aortic Coarctation) - HPO: HP:0001680 (Coarctation of aorta)

Synonyms/alternative names: Aortic coarctation; CoA; juxtaductal coarctation; preductal/postductal coarctation (older anatomic classification); "adult-type"/"infantile-type" coarctation (older terminology, largely superseded by isthmic-position terminology); aortic isthmus stenosis.

Data provenance: Most published knowledge is derived from aggregated disease-level resources — clinical case series, single- and multi-center cohort studies, national/regional birth-defect registries (e.g., EUROCAT, Utah Birth Defect Network, National Birth Defects Prevention Study), and genetic-association cohorts (e.g., the Pediatric Cardiac Genomics Consortium, deCODE genetics in Iceland) — rather than large-scale individual-patient EHR mining, reflecting CoA's status as a well-characterized but comparatively rare structural anomaly.

2. Etiology

Disease Causal Factors

CoA is fundamentally a disorder of abnormal aortic arch morphogenesis during fetal development, with a multifactorial etiology combining genetic susceptibility, altered fetal hemodynamics, and (rarely) monogenic/chromosomal causes. It is not caused by a single deterministic gene in the vast majority of cases; isolated non-syndromic CoA is best understood as a complex-trait cardiac malformation with substantial heritability (estimated at 58%) but incomplete penetrance and variable expressivity (search results, family-study literature; PMID:1018301, "A family study of coarctation of the aorta").

Genetic Risk Factors

Causal/high-confidence genes: - NOTCH1 — the most consistently implicated gene in isolated (non-syndromic) CoA. NOTCH1 encodes a transmembrane receptor central to endocardial cushion epithelial-to-mesenchymal transition (EMT) and left ventricular outflow tract (LVOT) development. A targeted resequencing study found the p.R1279H variant "significantly overrepresented in patients with aortic coarctation" — identified in 14% of CoA cases vs. 2% of controls — leading investigators to propose it as a disease-susceptibility allele (Freylikhman et al. 2014, Congenital Heart Disease, PMID:24418111). NOTCH1 mutations were separately shown to reduce ligand-induced Notch signaling in individuals with LVOT malformations (PMID:18593716). - MYH6 (myosin heavy chain 6, α-myosin heavy chain) — an Icelandic population-based GWAS/sequencing study (120 cases, >355,000 controls, using whole-genome sequencing imputed across the population) identified the rare missense variant p.Arg721Trp (R721W) with a striking effect size: OR = 44.2, P = 5.0×10⁻²², present in up to 20% of Icelandic CoA cases vs. ~1% of controls — "the first mutation associated with non-familial or sporadic CoA at a population level" (Gudbjartsson/Helgadottir et al. 2018, European Heart Journal, PMID:29590334). The variant lies in the converter domain of α-myosin heavy chain, critical for the ATP-hydrolysis-driven conformational change of the myosin lever arm, and separately associates with bicuspid aortic valve, sick sinus syndrome, and atrial fibrillation. - MCTP2 (multiple C2 and transmembrane domain-containing 2) — identified through 15q26.2 microdeletions in patients with CoA and hypoplastic left heart syndrome; a dosage-sensitive gene required for cardiac outflow tract development. Zebrafish/functional studies show Mctp2 morphants fail endocardial-to-mesenchymal transition in the outflow tract, phenocopying Notch1-deficient models (PMC3792692; QJM case report of a novel heterozygous MCTP2 mutation, academic.oup.com/qjmed). - SMAD6 — a negative regulator of BMP/TGF-β signaling (pathways essential for cardiac and aortic arch development); loss-of-function SMAD6 variants have been reported in probands with LVOT anomalies including CoA, bicuspid aortic valve, and hypoplastic transverse arch, sometimes with additional dysmorphic/developmental features when co-occurring with other variants (e.g., SMARCA4). - GATA5 — implicated alongside NOTCH1 and SMAD6 in bicuspid aortic valve and associated aortic arch abnormalities. - NKX2-5 — cardiac transcription factor found mutated in one or a few CoA individuals (typically in the context of broader congenital heart disease). - Copy-number-variant-associated genes with CoA-like phenotypes on mouse knockout: MATR3, FOXC1 (both found within CNV regions in CoA patients). - PRDM6 — recently reported in association with patent ductus arteriosus and coarctation of the aorta (PMID:38071433).

Susceptibility loci / polygenic contribution: Beyond single high-effect variants, CoA shows evidence of a broader oligogenic/polygenic architecture; a 2022 study ("Rare and Common Variants Uncover the Role of the Atria in Coarctation of the Aorta," Genes 2022, doi:10.3390/genes13040636) implicates additional common and rare variant burden, including an atrial-development component.

Chromosomal/syndromic associations: - Turner syndrome (45,X) — one of the strongest genetic risk associations. Bicuspid aortic valve was found in 34% of 45,X individuals and aortic coarctation in 12.5% (PMID:23825392, "Bicuspid aortic valve and aortic coarctation are linked to deletion of the X chromosome short arm in Turner syndrome"). Haploinsufficiency for Xp genes is implicated in abnormal aortic valve/arch development. - 22q11.2 deletion syndrome — CoA occurs occasionally among the conotruncal/aortic-arch anomaly spectrum of this syndrome (alongside interrupted aortic arch type B, vascular rings, and aberrant subclavian origin), though it is far less characteristic than in Turner syndrome. - PHACE(S) syndrome — more than 30% of PHACES patients have coarctation of the aorta or other aortic anomalies (arch atresia, aberrant subclavian origin, descending thoracic aortic hypoplasia, double aortic arch). - Noonan syndrome, Williams syndrome (elastin arteriopathy) — reported with distinctive, though generally less frequent, patterns of aortic arch/CoA involvement, consistent with each syndrome's characteristic cardiovascular phenotype spectrum. - Generalized arterial calcification of infancy (ABCC6/ENPP1 mutations) — can mimic severe neonatal coarctation clinically (PMC9807665) — a Named-Entity-Confusion-relevant differential to note in curation.

Environmental Risk Factors

Direct literature-confirmed environmental/maternal risk factors specific to CoA are less robustly characterized than for some other congenital heart defects, but general congenital-heart-defect teratogen/exposure literature (maternal pregestational diabetes, certain teratogenic medication exposures, maternal obesity, and other periconceptional exposures) is broadly implicated in left-sided obstructive lesions as a class; CoA is conventionally modeled as arising from the interaction of a genetic susceptibility background with altered fetal intracardiac and aortic arch flow dynamics (see Mechanism, below) rather than from a single discrete teratogen.

Protective Factors

No well-established genetic or environmental protective factors specific to CoA are documented in the literature reviewed; this is an area flagged as a knowledge gap.

Gene-Environment Interactions

The dominant mechanistic gene-by-hemodynamics interaction is the "hemodynamic theory": any genetic or structural lesion that reduces fetal blood flow through the left ventricle, aortic valve, and transverse aortic arch/isthmus during development (e.g., a ventricular septal defect that shunts flow preferentially to the right heart and pulmonary circulation, reducing left-to-aortic flow) predisposes to arch underdevelopment and coarctation — i.e., low-flow states during a critical developmental window interact with baseline genetic susceptibility to produce the coarctation phenotype (PMC11846778, "The onset of coarctation of the aorta before birth: Mechanistic insights from fetal arch anatomy and haemodynamics").

3. Phenotypes

CoA's phenotypic presentation is strongly age- and severity-dependent, spanning neonatal cardiogenic shock to incidental adult hypertension.

Cardinal signs (all ages)

Phenotype HPO term (suggested) Notes
Coarctation of aorta (the lesion itself) HP:0001680
Upper-extremity hypertension HP:0004420 (Hypertension) Systolic BP gradient >20 mmHg between upper and lower extremities is considered diagnostic
Diminished/absent/delayed femoral pulses HP:0031650 (Decreased pulse pressure) / clinical sign, "brachial-femoral delay" Pathognomonic physical exam finding
Systolic ejection murmur (interscapular/back) HP:0030148 (Heart murmur)
Differential cyanosis (lower body, if PDA-dependent with right-to-left shunt) HP:0025487 Neonatal, ductal-dependent presentations

Neonatal/infant presentation (severe/critical CoA)

  • Heart failure, respiratory distress, poor feeding (HP:0001635, Congestive heart failure; HP:0011098; HP:0011968, feeding difficulties)
  • Tachypnea, hepatomegaly (HP:0031692; HP:0002240)
  • Poor perfusion: mottling, cool/pale lower extremities, weak/absent femoral pulses
  • Cardiogenic shock and metabolic acidosis when the ductus arteriosus closes ("ductal-dependent" critical CoA), typically manifesting in the first 1–2 weeks of life

Older children/adolescent/adult presentation (milder/undiagnosed CoA)

  • Headache, epistaxis, dizziness (HP:0002315, HP:0000421)
  • Lower-limb claudication/exercise intolerance, leg fatigue (HP:0003546, Claudication)
  • Exertional dyspnea, fatigue
  • Systemic (upper-body) hypertension, often incidentally discovered
  • Cold extremities/leg cramps with exertion

Radiographic/imaging signs

  • Rib notching (posterior/inferior rib erosion from dilated, tortuous intercostal collateral arteries) — a classically taught pathognomonic chest radiograph finding, HP:0000895 (Abnormality of the ribs) or more specifically the descriptive term "rib notching."
  • "3-sign"/"figure-3 sign" on chest X-ray from the indented coarctation segment with pre- and post-stenotic dilation.
  • Extensive collateral circulation (internal mammary, intercostal, scapular arterial network) visible on CT/MR angiography.

Associated structural cardiac anomalies (frequently co-occurring, not strictly "phenotypes" of CoA per se but part of the disease spectrum)

  • Bicuspid aortic valve — present in ~50% of CoA patients (and, conversely, ~10% of BAV patients have CoA) (HP:0001647, Bicuspid aortic valve)
  • Ventricular septal defect
  • Mitral valve anomalies (parachute mitral valve)
  • Hypoplasia of the transverse aortic arch
  • Subaortic stenosis (as part of Shone complex)

Characteristics

  • Age of onset: Bimodal — critical/severe CoA presents neonatally (ductal-dependent, first days to 2 weeks of life); milder discrete CoA can remain silent until childhood, adolescence, or adulthood, when it is discovered via hypertension workup or incidental exam.
  • Severity: Highly variable — from a mild, hemodynamically insignificant narrowing to a critical, ductal-dependent obstruction causing neonatal shock.
  • Progression: In unrepaired disease, the obstruction and its downstream consequences (hypertension, collateral formation, LV hypertrophy) are generally progressive over years to decades; sudden decompensation occurs in neonates coincident with ductal closure.
  • Frequency data: BAV co-occurs in ~50% of CoA cases; intracranial aneurysm prevalence is significantly elevated versus the general population (see Outcome/Prognosis, below, for pooled estimates).

Quality of Life Impact

Long-term QoL burden centers on: chronic antihypertensive medication dependence, exercise limitation/claudication symptoms, anxiety around recoarctation/aneurysm surveillance imaging, and, in a subset, neurocognitive or psychosocial burden associated with lifelong cardiology follow-up starting in infancy. Dedicated CoA-specific EQ-5D/SF-36 data are less commonly reported in the literature surveyed than general adult congenital heart disease (ACHD) quality-of-life studies; this is flagged as an area with a data gap.

4. Genetic/Molecular Information

Causal Genes (summary table)

Gene HGNC/Gene ID Role in CoA Key variant Evidence type
NOTCH1 HGNC:7881 LVOT/endocardial cushion EMT p.R1279H Human cohort, functional
MYH6 HGNC:7576 Cardiac sarcomere (α-MHC) p.R721W (rs150793538) Population GWAS/WGS
MCTP2 HGNC:29669 Outflow tract EMT (Ca²⁺-sensing membrane protein) 15q26.2 microdeletion; point mutations Human CNV + zebrafish morphant
SMAD6 HGNC:6771 BMP/TGF-β signaling negative regulator Loss-of-function variants Human cohort
GATA5 HGNC:4174 Cardiac transcription factor Rare variants Human cohort
NKX2-5 HGNC:2488 Cardiac transcription factor Rare variants Human cohort (few individuals)
PRDM6 HGNC:14002 Transcriptional regulator, vascular smooth muscle Rare variants Human case reports
MATR3, FOXC1 — CNV-region candidate genes CNV Mouse knockout phenocopy

Variant classification / functional consequences

  • NOTCH1 p.R1279H: Missense; proposed disease-susceptibility allele; reduces ligand-induced Notch signaling.
  • MYH6 p.R721W: Missense (Arg→Trp), located in the myosin converter domain; large effect size (OR 44.2) but incomplete penetrance, consistent with a major-effect risk allele rather than a fully penetrant Mendelian mutation; also confers risk for BAV and arrhythmia phenotypes (sick sinus syndrome, atrial fibrillation), indicating pleiotropy across cardiac structural and electrical phenotypes.
  • MCTP2: Haploinsufficiency mechanism (dosage-sensitive gene); microdeletion (15q26.2, ~2.2 Mb in reported half-siblings) and point mutations both implicated — loss-of-function.
  • SMAD6: Predicted loss-of-function (pLOF) variants reported; consistent with de-repression of BMP/TGF-β signaling.

Allele frequency / population data

  • MYH6 p.R721W: population frequency 0.34% in the Icelandic reference population (gnomAD/deCODE data), markedly enriched in cases (up to 20%).
  • NOTCH1 p.R1279H: present in ~2% of controls vs. 14% of CoA cases (still detectable at low frequency in the general population, consistent with reduced penetrance / susceptibility-allele model rather than fully penetrant disease-causing mutation).

Somatic vs. germline origin

All reported CoA-associated variants are germline; there is no established somatic-mosaicism or acquired-mutation literature for CoA (as expected for a congenital structural malformation).

Modifier genes

Formal modifier-gene literature specific to CoA severity is sparse; MYH6 p.R721W's pleiotropic association with arrhythmia phenotypes suggests it may act as a modifier of long-term cardiovascular risk beyond the structural lesion itself, but this is not yet formally established as a "modifier" in the strict sense.

Epigenetic Information

No CoA-specific DNA methylation/histone-modification/chromatin studies were identified in the literature surveyed; this is a knowledge gap. (General congenital-heart-disease epigenomic studies exist but are not CoA-specific.)

Chromosomal Abnormalities

  • 45,X (Turner syndrome) — most significant recurring chromosomal association (see Etiology).
  • 22q11.2 deletion — occasional CoA co-occurrence within its broader conotruncal/aortic arch anomaly spectrum.
  • 15q26.2 terminal deletion (encompassing MCTP2) — reported in CoA/HLHS.

Suggested ontology terms

  • HGNC: NOTCH1 (HGNC:7881), MYH6 (HGNC:7576), MCTP2 (HGNC:29669), SMAD6 (HGNC:6771), GATA5 (HGNC:4174), NKX2-5 (HGNC:2488)
  • GO (biological process): GO:0007507 (heart development), GO:0003151 (outflow tract morphogenesis), GO:0003172 (determination of heart left/right asymmetry — for arch laterality anomalies), GO:0001570 (vasculogenesis), GO:0007219 (Notch signaling pathway), GO:0030509 (BMP signaling pathway)
  • GO (molecular function): GO:0005112 (Notch binding)

5. Environmental Information

  • Environmental factors: No specific toxin, radiation, or occupational-exposure literature dedicated to CoA was identified; CoA is grouped within the broader congenital-heart-defect teratogen literature.
  • Lifestyle factors: Maternal factors generally implicated in congenital heart defects as a class (pregestational diabetes, obesity) are relevant risk-modulators; CoA-specific quantification (odds ratios) was not identified in this search pass and should be sourced from national birth-defect registry studies (e.g., National Birth Defects Prevention Study) in a follow-up literature pass if precise ORs are required for curation.
  • Infectious agents: Not applicable — CoA is not an infectious disease. (Note: infective endocarditis is a downstream complication of CoA, not a cause — see Outcome/Prognosis.)

This section is flagged as an area with comparatively thin direct literature relative to the genetic etiology; downstream curation should treat environmental risk factors as a secondary/contributory layer atop the dominant genetic-hemodynamic model.

6. Mechanism / Pathophysiology

Causal chain overview

CoA pathophysiology operates on two nested timescales: (1) developmental — how the coarctation forms in utero/perinatally, and (2) hemodynamic/systemic — how the fixed anatomic narrowing produces its downstream physiological and vascular consequences across the lifespan.

6a. Developmental mechanism: two complementary/competing theories

1. Ductal tissue theory. The dominant unifying mechanism: the ductus arteriosus is largely composed of oxygen-sensitive smooth muscle arranged longitudinally/spirally, histologically distinct from the aorta's circumferentially arranged elastic fibers. Ectopic ductal smooth-muscle tissue can extend into (or migrate into) the periductal aortic wall at the isthmus. After birth, rising arterial oxygen tension triggers constriction of this ductal-type smooth muscle — the same physiological signal that normally closes the ductus arteriosus — and because this tissue is embedded circumferentially or eccentrically within the juxtaductal aortic wall, its contraction produces a discrete luminal narrowing of the aorta itself, not just ductal closure ("Pathology and molecular mechanisms of coarctation of the aorta and its association with the ductus arteriosus," J Physiol Sci, link.springer.com/article/10.1007/s12576-016-0512-x). This explains why some neonates with critical coarctation and a closed ductus arteriosus still respond to prostaglandin E1 (PGE1) infusion by relaxing ectopic ductal tissue surrounding the isthmus, relieving obstruction independent of reopening the ductus arteriosus itself (Springer, Pediatric Cardiology 2003, "Effectiveness of Prostaglandin E1 in Relieving Obstruction in Coarctation of the Aorta Without Opening the Ductus Arteriosus").

2. Hemodynamic (flow) theory. Coarctation results from reduced fetal blood flow volume through the aortic arch and isthmus during development. Any lesion diverting left ventricular output away from the ascending aorta/arch (e.g., a large ventricular septal defect preferentially shunting flow to the pulmonary circuit, or intrinsically reduced left heart forward flow) reduces the trophic flow stimulus needed for normal isthmic growth, producing arch underdevelopment/hypoplasia and coarctation. This is supported by embryologic/biomechanical modeling work (PMC11846778, "The onset of coarctation of the aorta before birth: Mechanistic insights from fetal arch anatomy and haemodynamics") and explains the strong empirical association between CoA and lesions that reduce left-sided flow (VSD, mitral stenosis, hypoplastic left heart spectrum).

These two theories are not mutually exclusive — abnormal ductal tissue and reduced fetal arch flow likely interact, with genetic lesions (NOTCH1, MYH6, MCTP2, SMAD6) predisposing to both defective outflow-tract EMT/morphogenesis and to the downstream flow abnormalities that exacerbate isthmic underdevelopment.

6b. Embryologic basis

The aortic arch system derives from the pharyngeal (branchial) arch arteries. The left 4th aortic arch forms the thoracic aortic arch/isthmus; the left 6th aortic arch forms the ductus arteriosus. Coarctation is attributed to abnormal embryologic development/remodeling of the left 4th and 6th arches at their isthmic junction — mechanistically related to, but distinct from, the pharyngeal-arch neural-crest-patterning defects captured elsewhere in cardiac malformation biology (this dismech instance's pharyngeal_arch_patterning_serial_homology module models the craniofacial/neural-crest arm; CoA's arch-artery-remodeling defect is a related but separate vascular morphogenesis process, chiefly involving cardiac neural crest and second heart field contributions to the outflow tract/aortic arch rather than the facial skeletal neural crest program).

6c. Cellular/molecular processes at the lesion

  • Endocardial-to-mesenchymal transition (EMT) failure in the outflow tract/endocardial cushions — the shared mechanistic node linking NOTCH1 and MCTP2: Notch1-deficient mouse embryos "fail to form endocardial cushions" with "absence of mesenchymal cells migrating from the endocardium," phenotypically mirrored in Mctp2 morphants, which show "intact myocardial and endocardial layers of the outflow tract in the presence of cardiac jelly," indicating failed EMT (PMC3792692).
  • Vascular smooth muscle cell (VSMC) phenotypic modulation: Within the coarctation segment itself, "smooth muscle cells in the intima of CoA stenotic segments dedifferentiate at an early stage and redifferentiate in older populations." The lesion is characterized by intimal thickening, impaired elastic fiber formation, and phenotypic modulation of VSMCs.
  • Systemic arteriopathy beyond the discrete lesion: Resected pre-stenotic aortic tissue shows reduced contractility, increased collagen deposition, and reduced smooth muscle content — indicating CoA is "a systemic vascular disease rather than a simple mechanical obstruction that can be resolved through surgical intervention alone." This underlies the persistence of hypertension and proatherogenic vascular changes even after anatomically successful repair.

6d. Post-lesion hemodynamic cascade (the causal chain from anatomic lesion to clinical manifestation)

  1. Fixed luminal obstruction at the aortic isthmus →
  2. Increased afterload on the left ventricle proximal to the coarctation, and reduced perfusion pressure distal to it →
  3. Compensatory collateral arterial network formation — blood is rerouted anterogradely through the subclavian/internal mammary/intercostal arterial system with retrograde flow through the intercostal arteries back into the descending aorta distal to the coarctation, producing the radiographically visible rib notching sign (from chronic pulsatile pressure erosion of the inferior rib cortex) →
  4. Left ventricular hypertrophy/remodeling from chronic pressure overload →
  5. Persistent systemic (upper-body) hypertension, mediated in part by altered aortic arch baroreceptor function: baroreceptors situated in the abnormally rigid/dilated pre-stenotic aortic segment are activated less at a given pressure than baroreceptors in a normally distensible vessel, resetting the baroreflex to tolerate — and defend — a higher systemic pressure ("Hypertension and coarctation of the aorta: an inevitable consequence of developmental pathophysiology," Hypertension Research, nature.com/articles/hr201122) →
  6. Downstream end-organ consequences: premature atherosclerosis/coronary artery disease, intracranial (berry) aneurysm formation and rupture, aortic aneurysm/dissection at or near the repair site, left ventricular dysfunction/heart failure, and increased infective endocarditis risk from turbulent flow across the lesion or associated bicuspid valve.

Critically, this arteriopathy/baroreflex-resetting mechanism explains the clinically important observation that hypertension frequently persists after anatomically successful surgical or catheter-based repair, since the systemic vascular and baroreceptor abnormalities are not confined to the resected/dilated segment alone — "CoA is a lifelong disease strongly associated with long-term hypertension, regardless of age at diagnosis or quality of repair" (Hypertension, AHA Journals, "Coarctation of the Aorta: Modern Paradigms Across the Lifespan," doi:10.1161/HYPERTENSIONAHA.123.19454).

Suggested GO / CL / UBERON terms for pathophysiology modeling

  • GO:BP: GO:0007507 (heart development), GO:0003151 (outflow tract morphogenesis), GO:0001525 (angiogenesis, for collateral formation), GO:0001974 (blood vessel remodeling), GO:0035904 (aorta development), GO:0003416 (endochondral bone growth — n/a), GO:0006940 (regulation of smooth muscle contraction)
  • GO:CC: GO:0005886 (plasma membrane, for VSMC phenotypic markers)
  • CL: CL:0000359 (vascular associated smooth muscle cell), CL:0002350 (endocardial cell), CL:0000057 (fibroblast, for collagen deposition), CL:0000669 (pericyte, if collateral vessel remodeling context needed)
  • UBERON: UBERON:0001496 (aortic arch), UBERON:0001508 (descending aorta), UBERON:0009834 (aortic isthmus — check exact term availability), UBERON:0002049 (ductus arteriosus / vasculature of the heart region), UBERON:0002100 (trunk vasculature)

7. Anatomical Structures Affected

Organ level

  • Primary: Aorta (specifically the aortic isthmus/proximal descending thoracic aorta), left ventricle (pressure-overload hypertrophy secondary to obstruction).
  • Secondary/complication-related organs: Brain (intracranial/berry aneurysm, hemorrhagic stroke risk), coronary arteries (premature atherosclerosis), kidneys (renin-angiotensin activation contributing to hypertension), heart valve (bicuspid aortic valve, frequently co-occurring), lower extremities (hypoperfusion, claudication).
  • Body systems involved: Cardiovascular system primarily; secondary CNS and renal involvement via hypertension-mediated end-organ effects.

Tissue and cell level

  • Aortic tunica media/intima at the coarctation segment: smooth muscle phenotypic modulation, intimal thickening, disrupted elastic lamellae.
  • Pre-stenotic aortic wall: increased collagen, reduced smooth muscle content, reduced contractility (systemic arteriopathy).
  • Collateral vessel network: internal mammary arteries, intercostal arteries, scapular anastomotic network — chronically dilated/tortuous.

Subcellular level

Not deeply characterized in CoA-specific literature at the organelle level; the dominant subcellular process is VSMC phenotypic switching (contractile → synthetic phenotype), a broadly recognized vascular biology process (GO:0035886, vascular associated smooth muscle cell differentiation).

Localization

  • Anatomical site: Aortic isthmus (junction of aortic arch and descending thoracic aorta), typically juxtaductal (adjacent to the ductus arteriosus insertion) — UBERON term for aortic isthmus should be verified via OAK lookup during curation.
  • Laterality: Not applicable in the traditional bilateral-organ sense, but note the "differential cyanosis" pattern (lower body vs. upper body) in ductal-dependent neonatal presentations reflects the coarctation's position relative to the ductus arteriosus and brachiocephalic vessel origins.

8. Temporal Development

Onset

  • Congenital — the anatomic lesion is present at birth (or forms perinatally via ductal-tissue constriction as described above), though clinical detection may be delayed.
  • Onset pattern: Can be acute (neonatal ductal-dependent presentation, days 1–14 of life, precipitated by ductus arteriosus closure) or insidious/chronic (asymptomatic until incidental hypertension detection in childhood, adolescence, or adulthood).

Progression

  • Neonatal critical CoA: Rapid, life-threatening progression to cardiogenic shock/multiorgan hypoperfusion within days of ductal closure if unrecognized — a true pediatric cardiac emergency.
  • Milder/undiagnosed CoA: Slowly progressive over years to decades — progressive collateral formation, progressive LV hypertrophy, progressive systemic hypertension, and (without early diagnosis) potential progression to intracranial hemorrhage, aortic dissection, or premature coronary disease by the third–fourth decade of life if untreated.
  • Post-repair: Recoarctation can develop at the repair site over months to years; aortic aneurysm formation at the repair site is a recognized late complication requiring lifelong surveillance.

Patterns

  • Disease course: Predominantly a fixed anatomic lesion with superimposed progressive systemic vascular sequelae (arteriopathy, hypertension) rather than a relapsing-remitting pattern.
  • Critical period: The perinatal window around ductal closure (typically the first 1–2 weeks of life) is the single most important critical period — this is when ductal-dependent critical coarctation manifests and when prostaglandin E1 rescue is time-sensitive and life-saving.
  • No spontaneous remission — the anatomic narrowing does not resolve without surgical or catheter-based intervention.

9. Inheritance and Population

Epidemiology

  • Birth prevalence: approximately 1/2,500 live births (isolated CoA); alternative estimates cite 3–4 per 10,000 live births, or ~29–49 per 100,000 live births — broadly consistent figures across sources.
  • Proportion of congenital heart defects: CoA accounts for 4–6% of all congenital heart defects, making it one of the more common structural cardiac anomalies.

Inheritance pattern

  • CoA is generally considered multifactorial/complex rather than following simple Mendelian inheritance in the large majority of non-syndromic cases, though it clusters in families more strongly than most other congenital heart lesions.
  • Heritability estimate: 58% (family-based studies).
  • Sibling recurrence risk: Historical teaching cited ~1 in 200 (0.5%), but more recent, better-powered estimates report a sibling recurrence risk of 4.0% (95% CI: 2.1–6.7%) — notably elevated (reportedly >30-fold) relative to the general-population baseline risk for any congenital heart defect (~1%). If more than one sibling is already affected, recurrence risk can rise to ~10%. (PMID:1018301, "A family study of coarctation of the aorta"; supplementary recurrence-risk literature.)
  • Penetrance: Reduced/incomplete for the identified susceptibility alleles (NOTCH1 p.R1279H present at low frequency even in unaffected controls; MYH6 p.R721W similarly not fully penetrant), consistent with a complex-trait, multi-hit model rather than classic Mendelian dominant/recessive inheritance for isolated CoA. (Syndromic CoA, e.g., in the context of a defined 15q26.2 deletion or Turner syndrome, follows the inheritance/penetrance pattern of the underlying chromosomal condition.)
  • Genetic anticipation: Not reported/applicable.
  • Founder effects: The Icelandic MYH6 p.R721W finding — enriched to ~20% of local CoA cases — is consistent with a population-specific (founder-influenced) allele frequency effect, illustrating how population genetic background modulates observed genetic architecture.
  • Consanguinity: Not specifically highlighted as a major driver in the literature surveyed (befitting the multifactorial rather than autosomal-recessive model).

Population demographics

  • Sex ratio: Consistent male predominance, reported across sources at roughly 1.3:1 to 1.7:1 male:female (some individual series report up to 59%:41% or higher); this is one of relatively few congenital heart defects with a clear male excess.
  • Geographic/ethnic distribution: No strong evidence of major geographic clustering beyond population-specific allele frequency effects (e.g., the Icelandic MYH6 founder variant); Turner syndrome-associated CoA prevalence is a function of Turner syndrome's own population frequency (~1/2,000–2,500 live female births) rather than an independent geographic pattern.
  • Age distribution: Bimodal clinical detection — neonatal/infant presentation for severe/critical lesions, and childhood-through-adult presentation (often via incidental hypertension screening) for milder lesions.

10. Diagnostics

Clinical/physical examination

  • Four-limb blood pressure measurement is a cornerstone diagnostic maneuver — a systolic BP gradient >20 mmHg between upper and lower extremities is considered suggestive of significant coarctation; guideline-based pediatric hypertension evaluation includes four-limb BP assessment.
  • Brachial-femoral pulse delay/differential — "pathognomonic" on exam alongside the BP gradient.
  • Auscultation: systolic murmur, often best heard over the back/interscapular region.

Imaging

  • Transthoracic echocardiography (TTE): the preferred first-line diagnostic modality for both initial diagnosis and follow-up; most CoA cases are diagnosed by echo.
  • Cardiac MRI / CT angiography: second-line advanced imaging providing detailed anatomic delineation of the arch, isthmus, and collateral vessels; particularly valuable for surgical/interventional planning and long-term adult surveillance (repair-site aneurysm, recoarctation).
  • Chest radiograph: classic but non-sensitive supportive findings — rib notching (from chronic intercostal collateral erosion of the inferior rib margins) and the "figure-3 sign" from the indented coarctation segment with pre-/post-stenotic dilation; "regression of rib notching following surgery" has been documented radiographically, useful as an indirect marker of successful repair.

Fetal/prenatal diagnosis

  • Fetal echocardiography allows prenatal detection but remains challenging — the intracardiac structures are typically normal in isolated CoA, and the aortic arch/isthmus itself is technically difficult to visualize directly in utero.
  • Diagnosis is most often inferred indirectly from right-left ventricular and great-vessel size disproportion (right-sided predominance) — but this sign alone has limited specificity: in one study, only ~30% of fetuses flagged for suspected coarctation based on ventricular disproportion were confirmed postnatally (i.e., a substantial false-positive rate with ventricular disproportion as sole criterion).
  • Multi-parameter prediction models improve accuracy: aortic valve z-score (best cutoff −1.25) and distal transverse aortic arch z-score (best cutoff −0.37) were identified as the best individual predictors of postnatal CoA confirmation; combining multiple third-trimester echocardiographic parameters improves prediction over any single criterion.

Genetic testing

  • No single-gene test is diagnostic for the majority of isolated CoA cases, given its multifactorial/complex architecture; genetic testing is generally targeted at:
  • Chromosomal microarray/karyotype — particularly indicated to evaluate for Turner syndrome (45,X) in females and for 22q11.2 deletion when other syndromic features or additional conotruncal anomalies are present.
  • Gene panel testing for LVOT-malformation-associated genes (NOTCH1, MYH6, SMAD6, GATA5, NKX2-5) may be considered in familial or syndromic presentations, though clinical-grade panels and their yield are still evolving given the incomplete-penetrance, complex-trait nature of most isolated cases.
  • Whole exome/genome sequencing has been the primary discovery tool for the individual gene associations above (research rather than routine first-line clinical context in most isolated cases currently).

Clinical criteria / differential diagnosis

Differential diagnosis for the BP-gradient/hypertension presentation includes: essential/primary hypertension, other causes of secondary pediatric hypertension (renal artery stenosis, pheochromocytoma), interrupted aortic arch (more severe, complete discontinuity rather than narrowing), and — importantly for evidence-quality curation — generalized arterial calcification of infancy (GACI, ABCC6/ENPP1), which can mimic severe neonatal coarctation on imaging (PMC9807665) — a differential worth flagging in curation to avoid conflating the two entities.

Screening

No population-wide dedicated newborn screening test exists for CoA specifically; pulse oximetry-based critical congenital heart disease (CCHD) newborn screening, implemented broadly in the US and many other health systems, is the principal population-level early-detection tool, since severe CoA can produce detectable pre-/post-ductal oxygen saturation differentials before overt clinical decompensation.

11. Outcome/Prognosis

Survival and mortality

  • Untreated critical/severe neonatal CoA is a life-threatening ductal-dependent lesion with high mortality if unrecognized and PGE1/surgical intervention is delayed.
  • With modern surgical/catheter-based repair, survival into adulthood is the norm for isolated CoA, but adults with repaired CoA carry increased long-term cardiovascular mortality compared to the general population, driven chiefly by hypertension-related sequelae (premature coronary disease, stroke, aortic complications) rather than the repaired lesion itself.
  • Untreated milder CoA historically carried a substantially reduced life expectancy by the third–fourth decade due to complications (hypertension, LV failure, dissection, intracranial hemorrhage), which is the historical rationale for early surgical correction once the lesion was recognized.

Morbidity / disease course complications

  • Persistent/recurrent hypertension post-repair: reported in roughly 30–50% of adults even after technically successful repair — the single most important chronic morbidity, reflecting the systemic arteriopathy/baroreflex-resetting mechanism described above rather than simple failure of the mechanical repair.
  • Recoarctation: recurrent narrowing at or near the repair site, requiring repeat catheter or surgical intervention in a meaningful subset of patients; risk factors for recurrence have been specifically studied in pediatric surgical cohorts (e.g., "Risk factors for recurrence after surgical repair of coarctation of the aorta in children: a single-center experience based on 51 children," PMC10267975).
  • Aortic aneurysm/pseudoaneurysm at the repair site — a recognized late complication, more frequent after certain repair techniques (notably historic Dacron patch aortoplasty) and after bare-metal stent placement (fatal complications including aortic rupture reported with bare stents, motivating the shift toward covered stents).
  • Premature coronary artery disease — increased risk of angina, MI, and sudden cardiac death.
  • Intracranial (berry) aneurysm: significantly elevated prevalence compared with the general population, with earlier age at rupture than typical sporadic intracranial aneurysms; a systematic review/meta-analysis specifically quantified this elevated prevalence (JACC: Advances, "Prevalence of Intracranial Aneurysms in Patients With Coarctation of the Aorta: A Systematic Review and Meta-Analysis," doi:10.1016/j.jacadv.2023.100394).
  • Infective endocarditis risk, related to turbulent flow across the coarctation and/or an associated bicuspid aortic valve.
  • Aortic dissection/rupture, particularly in longstanding untreated hypertensive disease.
  • Left ventricular hypertrophy and dysfunction/heart failure from chronic pressure overload, particularly if diagnosis/repair is delayed.

Recovery potential / prognostic factors

  • Earlier diagnosis and repair are associated with better long-term blood pressure control and reduced cardiovascular morbidity; delayed diagnosis (into later childhood/adulthood) is associated with a higher burden of established hypertension and arteriopathy that may not fully normalize even after mechanically successful repair.
  • Presence of associated lesions (bicuspid aortic valve, arch hypoplasia, VSD) and the extent of pre-existing systemic arteriopathy at the time of repair are relevant prognostic modifiers, though CoA-specific quantitative prognostic scoring systems were not identified in this search pass.

12. Treatment

Overarching goal

Eliminate (or substantially reduce) the aortic pressure gradient and relieve/prevent systemic hypertension, ideally with early intervention following diagnosis.

Pharmacotherapy

  • Prostaglandin E1 (alprostadil) — the critical first-line neonatal stabilization agent for ductal-dependent/critical CoA. Maintains (or, notably, can act even after) ductal patency and, importantly, directly relaxes ectopic ductal smooth-muscle tissue within the coarctation segment itself, relieving obstruction even without reopening a closed ductus arteriosus (a mechanistically distinct, dual-action benefit specific to CoA among ductal-dependent lesions). A Cochrane review addresses PGE1 use for maintaining ductal patency broadly across ductal-dependent cardiac lesions (Akkinapally et al. 2018, Cochrane Library, doi:10.1002/14651858.CD011417.pub2).
  • NCIT suggestion: NCIT:C15986 (Pharmacotherapy) as treatment_term, with therapeutic_agent bound to alprostadil (CHEBI or NCIT term — verify via OAK).
  • Antihypertensive medications for pre- and post-repair blood pressure management (ACE inhibitors/ARBs, beta-blockers commonly used in adult ACHD hypertension management, per general hypertension pharmacotherapy classes) — NCIT:C15986 Pharmacotherapy with an appropriate therapeutic_agent per specific drug class.

Surgical and interventional

  • Surgical repair remains the treatment of choice, particularly for neonates/young infants and for complex/long-segment coarctation not amenable to catheter approaches. Techniques include resection with end-to-end (or extended end-to-end) anastomosis, subclavian flap aortoplasty, and patch aortoplasty (historically associated with higher late aneurysm risk). NCIT suggestion: NCIT:C15329 (Surgical Procedure) or a more specific cardiothoracic/vascular surgical procedure term.
  • Balloon angioplasty — catheter-based dilation of the coarctation segment; now the preferred therapy for recurrent (post-surgical) coarctation when anatomy is favorable.
  • Stent implantation (bare-metal or covered): increasingly used, especially in older children/adults with native or recurrent coarctation. Covered balloon-expandable stents have emerged specifically to mitigate the aortic rupture/pseudoaneurysm risk associated with bare stents (Frontiers in Cardiovascular Medicine, "Endovascular treatment of aortic coarctation using covered balloon-expandable stents—a systematic review and meta-analysis," 2024, doi:10.3389/fcvm.2024.1439458).
  • Hybrid approaches — combined surgical/catheter strategies for complex arch anatomy (e.g., "Two stage hybrid approach for complex aortic coarctation repair," PMC2652448).
  • NCIT suggestion for catheter-based intervention: a specific NCIT interventional cardiology/angioplasty term (verify via OAK; general fallback NCIT:C49236 Therapeutic Procedure).

Supportive care

Neonatal stabilization (inotropic support, correction of metabolic acidosis, mechanical ventilation as needed) pending definitive PGE1 stabilization and surgical/catheter repair in critical presentations.

Treatment outcomes / adverse events

  • Bare-metal stents: associated with fatal complications including aortic rupture, pseudoaneurysm formation, and post-implantation aneurysm — a key driver of the shift toward covered stents.
  • Catheter interventions overall: "good [outcomes] in skilled hands, but residual or recurrent coarctation with resultant hypertension and repair site aneurysms can occur."

Treatment strategy / algorithms

  • Neonatal critical CoA: PGE1 stabilization → surgical repair (most common in this age group) or catheter intervention depending on center expertise/anatomy.
  • Recurrent/recoarctation: catheter-based balloon angioplasty ± stent is now generally preferred over reoperation when anatomy permits.
  • Adult native or recurrent CoA: individualized surgical vs. covered-stent decision-making based on anatomy, arch hypoplasia, and aneurysm risk.

Experimental / clinical trials

Specific active CoA-focused NCT-registered interventional trials were not individually enumerated in this pass; a dedicated ClinicalTrials.gov search (e.g., for covered stent devices, novel antihypertensive regimens in ACHD, or long-term arteriopathy-targeted therapy) would be the appropriate follow-up step for curation requiring specific NCT identifiers.

13. Prevention

Primary prevention

No established primary prevention strategy exists for CoA itself, given its developmental/multifactorial etiology; general prenatal care optimization (glycemic control in pregestational diabetes, avoidance of known teratogens) is the applicable general congenital-heart-defect prevention framework rather than a CoA-specific intervention.

Secondary prevention (early detection)

  • Pulse oximetry-based critical congenital heart disease newborn screening — the principal population-level early-detection tool, since it can flag pre-/post-ductal saturation differentials in severe CoA before overt decompensation.
  • Four-limb blood pressure screening in the context of routine pediatric hypertension evaluation serves as an important later-childhood/adolescent detection mechanism for milder, previously undiagnosed CoA.
  • Fetal echocardiography in pregnancies with risk factors (e.g., known familial CoA, other detected cardiac anomalies with left-right ventricular disproportion, Turner syndrome diagnosis) enables prenatal detection and delivery planning at a center capable of neonatal cardiac care, though — as noted — sensitivity/specificity limitations remain (see Diagnostics).

Tertiary prevention (preventing complications in diagnosed/repaired patients)

  • Lifelong cardiology follow-up with periodic imaging (echo, CT, or MRI) for recoarctation and aneurysm surveillance.
  • Aggressive blood pressure control post-repair to mitigate the premature coronary disease, intracranial aneurysm, and aortic complication risks driven by persistent hypertension.
  • Endocarditis-precaution counseling where indicated by associated valve pathology, per standard infective endocarditis prophylaxis guidelines.

Genetic counseling

Given the elevated sibling recurrence risk (~4%, and up to ~10% with more than one affected sibling) relative to the general congenital-heart-defect baseline, genetic counseling for families with an index CoA case is warranted, incorporating both the empirical recurrence-risk data and consideration of targeted testing (karyotype/microarray for Turner/22q11.2, gene panel where clinically indicated) depending on the presence of syndromic features.

Public health / screening programs

CoA detection is embedded within broader national/regional newborn CCHD pulse-oximetry screening programs rather than having a dedicated standalone public health screening program.

14. Other Species / Natural Disease

  • Taxonomy: Naturally occurring CoA has been documented in dogs (Canis lupus familiaris, NCBITaxon:9615) and, per the veterinary literature, is described as occurring (rarely) in cats as well; it has also been used as an induced/surgical model in rabbits and pigs.
  • Natural disease in companion animals: MSD/Merck Veterinary Manual describes CoA in animals as "a rare condition of dogs and cats" involving narrowing of the aorta distal to the subclavian artery, typically at/near the ductus arteriosus site, producing concentric left ventricular hypertrophy from pressure overload — directly analogous to the human mechanism. Documented breed case reports include a Great Dane with a large fusiform post-stenotic aneurysm and a Vizsla with juxtaductal coarctation identified at postmortem following sudden collapse/cardiopulmonary arrest during a stressful event (ScienceDirect, "Sudden death in a dog with aortic coarctation").
  • Clinical presentation in animals: Forelimb blood pressure readings are characteristically higher than hindlimb readings, directly mirroring the human upper-vs-lower-extremity gradient sign.
  • Veterinary relevance: Naturally occurring CoA remains rare in veterinary practice — "although AoCo is a well-recognized congenital defect in humans, it has been reported only rarely in animals" — with the available literature dominated by individual case reports rather than large breed-prevalence cohort studies; no confirmed OMIA (Online Mendelian Inheritance in Animals) breed-heritability entry was identified in this search pass.
  • Comparative pathology: The fundamental structural mechanism (juxtaductal narrowing, pressure-overload LV hypertrophy) is conserved across species, supporting the translational relevance of large-animal (porcine, ovine) surgical/hemodynamic coarctation models to human disease biology.

15. Model Organisms

Genetic/induced models

  • Mouse:
  • Notch1 haploinsufficient mice develop ascending aortic aneurysms, and Notch1-deficient mouse embryos fail endocardial cushion formation with absent endocardial-to-mesenchymal transition — directly modeling the EMT-failure mechanism proposed for human LVOT malformations including CoA (PMID:29093270, "Notch1 haploinsufficiency causes ascending aortic aneurysms in mice").
  • Myeloid-specific Notch1 knockout mice have been used to study aneurysm progression via TLR/oxidative-stress/SHP2 signaling pathways, offering a complementary post-natal vascular-inflammation angle on Notch1-related aortic pathology (PMC10866402).
  • Zebrafish:
  • Mctp2 morphants recapitulate failed outflow-tract EMT with intact myocardial/endocardial layers persisting in the presence of cardiac jelly — closely phenocopying the Notch1-deficient mouse defect and directly supporting MCTP2's causal role in human CoA/HLHS (PMC3792692, "MCTP2 is a dosage-sensitive gene required for cardiac outflow tract development").
  • Induced large-animal models:
  • Porcine (growing pig) model of surgically created/treated aortic coarctation, used for structural and mechanical wall analysis of treated vs. untreated coarctation over growth (bioRxiv, "Structural and Mechanical Analysis of Treated and Untreated Aortic Coarctation in a Growing Porcine Model," 2025).
  • Rabbit computational/surgical model examining ventricular and ascending aortic remodeling in response to induced coarctation (bioRxiv, "A Computational Model of Coarctation of the Aorta in Rabbits: Ventricular and Ascending Aortic Remodeling," 2023).
  • These large-animal surgical models are chiefly used to study the downstream hemodynamic/remodeling consequences of a fixed aortic narrowing (LV hypertrophy, ascending aortic wall remodeling, collateral development) rather than the developmental genetic etiology, complementing the developmental-genetics focus of the mouse/zebrafish models above.

Model characteristics and limitations

  • The mouse/zebrafish genetic models (Notch1, Mctp2) recapitulate the developmental/EMT-failure mechanism believed to underlie human outflow-tract and arch malformations but do not, on their own, produce a discrete adult-onset coarctation lesion identical to the human anatomic phenotype — they primarily model the upstream cellular defect (failed EMT, endocardial cushion formation) rather than the mature juxtaductal narrowing itself.
  • The large-animal surgically-induced models (porcine, rabbit) directly reproduce the mature anatomic lesion and its hemodynamic consequences but do not model the underlying developmental/genetic etiology — they are mechanical/hemodynamic models rather than etiologic models. This is a clear example of a model-fidelity split worth flagging for HUMAN_MODEL_MISMATCH-type discussion during curation: genetic models capture "why" the lesion forms; surgical large-animal models capture "what happens" once it exists — no single model captures both arms.
  • Applications: Genetic models are used to dissect the molecular/cellular basis of arch/outflow-tract malformation; surgically-induced large-animal models are used to study post-repair vascular remodeling, wall mechanics, and to test/optimize interventional devices (stents, angioplasty balloons) before human use.

Summary of Key Suggested Ontology Terms for KB Curation

Category Term(s)
Disease MONDO:0007345; OMIM:120000; Orphanet:1457; ICD-10:Q25.1; HP:0001680
Phenotypes HP:0004420 (Hypertension), HP:0001647 (Bicuspid aortic valve), HP:0001635 (CHF), HP:0003546 (Claudication), HP:0000895 (rib abnormality/notching)
Genes HGNC:7881 (NOTCH1), HGNC:7576 (MYH6), HGNC:29669 (MCTP2), HGNC:6771 (SMAD6), HGNC:4174 (GATA5), HGNC:2488 (NKX2-5)
GO:BP GO:0007507, GO:0003151, GO:0007219, GO:0030509, GO:0001974
CL CL:0000359 (vascular smooth muscle cell), CL:0002350 (endocardial cell)
UBERON UBERON:0001496 (aortic arch), UBERON:0001508 (descending aorta), ductus arteriosus term (verify)
NCIT (treatment) NCIT:C15986 (Pharmacotherapy — PGE1, antihypertensives), NCIT:C15329 (Surgical Procedure), catheter/angioplasty term (verify)
Associated syndromes Turner syndrome (MONDO term), 22q11.2 deletion syndrome (MONDO term), PHACE syndrome

Key Citations (PMID/DOI where available)

  1. Freylikhman et al. 2014. Variants in the NOTCH1 gene in patients with aortic coarctation. Congenit Heart Dis. PMID:24418111
  2. Garg et al. NOTCH1 mutations in individuals with left ventricular outflow tract malformations reduce ligand-induced signaling. PMID:18593716
  3. Gudbjartsson/Helgadottir et al. 2018. A rare missense mutation in MYH6 associates with non-syndromic coarctation of the aorta. Eur Heart J 39(34):3243. PMID:29590334
  4. "Rare and Common Variants Uncover the Role of the Atria in Coarctation of the Aorta." Genes 2022, 13(4):636. doi:10.3390/genes13040636 (PMC9032275)
  5. "MCTP2 is a dosage-sensitive gene required for cardiac outflow tract development." PMC3792692
  6. Novel heterozygous mutation of MCTP2 gene in a patient with coarctation of the aorta. QJM. academic.oup.com/qjmed
  7. Sharma et al. Bicuspid aortic valve and aortic coarctation are linked to deletion of the X chromosome short arm in Turner syndrome. PMID:23825392
  8. "A family study of coarctation of the aorta." PMID:1018301 / PMC1013466
  9. Freud et al. Notch1 haploinsufficiency causes ascending aortic aneurysms in mice. PMID:29093270
  10. "Pathology and molecular mechanisms of coarctation of the aorta and its association with the ductus arteriosus." J Physiol Sci. link.springer.com/article/10.1007/s12576-016-0512-x
  11. "Hypertension and coarctation of the aorta: an inevitable consequence of developmental pathophysiology." Hypertens Res. nature.com/articles/hr201122
  12. "Coarctation of the Aorta: Modern Paradigms Across the Lifespan." Hypertension (AHA), doi:10.1161/HYPERTENSIONAHA.123.19454
  13. "The onset of coarctation of the aorta before birth: Mechanistic insights from fetal arch anatomy and haemodynamics." PMC11846778
  14. "Effectiveness of Prostaglandin E1 in Relieving Obstruction in Coarctation of the Aorta Without Opening the Ductus Arteriosus." Pediatr Cardiol 2003. link.springer.com
  15. Akkinapally et al. 2018. Prostaglandin E1 for maintaining ductal patency in neonates with ductal-dependent cardiac lesions. Cochrane Database Syst Rev. doi:10.1002/14651858.CD011417.pub2
  16. "Endovascular treatment of aortic coarctation using covered balloon-expandable stents—a systematic review and meta-analysis." Front Cardiovasc Med 2024. doi:10.3389/fcvm.2024.1439458
  17. "Prevalence of Intracranial Aneurysms in Patients With Coarctation of the Aorta: A Systematic Review and Meta-Analysis." JACC Adv 2023. doi:10.1016/j.jacadv.2023.100394
  18. "Risk factors for recurrence after surgical repair of coarctation of the aorta in children." PMC10267975
  19. Coarctation of the Aorta - StatPearls. NCBI Bookshelf NBK430913
  20. Coarctation of the Aorta in Animals. MSD Veterinary Manual.
  21. PRDM6 variants: Patent ductus arteriosus and coarctation of the aorta in association with PRDM6 variants. PMID:38071433
  22. SMAD6 pLOF variants in LVOT anomalies (multiple sources, ScienceDirect P218 abstract; PMC7549564)
  23. "Isolated Coarctation of the Aorta: Current Concepts and Perspectives." PMC9174545
  24. Orphanet: Coarctation of aorta. orpha.net/en/disease/detail/1457
  25. OMIM 120000 — Coarctation of Aorta. omim.org/entry/120000

Note on evidence gaps for curation: Direct quantified environmental/lifestyle risk-factor data specific to CoA (as opposed to congenital heart defects generally), CoA-specific quality-of-life instrument data, epigenomic/methylation studies, and an authoritative OMIA veterinary heritability entry were not identified in this search pass and should be treated as open items for a follow-up literature sweep before being asserted as curated claims with citations.